This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other factor of the environment
VWXY20_OTHER_FACTOR_ENVIRONMENT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
494 |
4. Check minimum number of eventsNone |
494 |
5. Include endpointsNone |
494 |
6. Filter based on genotype QC (FinnGen only) |
472 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Y9
Similar endpoints
↥List of similar endpoints to
Other factor of the environment
based on the number of shared cases.
Similar with more cases:
- Supplementary factors related to causes of morbidity and mortality classified elsewhere
- External causes of morbidity and mortality
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 472 | 262 | 210 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.10 |
| Median age at first event (years) | 57.54 | 52.20 | 64.21 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 494
- Matched controls
- 4940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y98
ICD-10 Finland
Lifestyle-related condition
+∞
307.7
451
*
T78.4
ICD-10 Finland
Allergy, unspecified
12.2
78.7
85
83
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
9.7
47.1
58
67
T78.3
ICD-10 Finland
Angioneurotic oedema
17.8
45.7
38
23
Y97
ICD-10 Finland
Environmental-pollution-related condition
+∞
45.5
43
*
NHQ40
NOMESCO Finland
Amputation of toe
14.9
39.5
36
26
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
8.8
38.7
51
64
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.4
33.1
58
100
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
31.1
150
568
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.4
30.8
54
93
Y96.9
ICD-10 Finland
Unspecified type of accident
285.8
27.0
27
*
A46
ICD-10 Finland
Erysipelas
3.3
24.6
109
387
ZZA00
NOMESCO Finland
Split skin graft
8.2
24.1
33
43
J01FF01
ATC
clindamycin; systemic
2.7
23.9
185
892
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
23.0
98
338
S97
ICPC
Chronic ulcer skin
4.3
22.2
61
155
N02AA05
ATC
oxycodone; systemic
2.9
22.1
125
509
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.7
21.6
28
34
TQW11
NOMESCO Finland
Vacuum treatment of wound
8.3
21.5
29
37
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
21.0
87
294
SPAT1229
SPAT
Assessment of need for aid
4.4
20.4
55
138
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.6
20.0
72
222
WZC00
NOMESCO Finland
Treatment plan or consultation
2.4
19.0
227
1310
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
5.0
18.8
42
90
L28
ICPC
Limited function/disability (L)
2.7
18.4
117
503
A06AD11
ATC
lactulose; oral
3.0
18.2
93
355
SPAT1301
SPAT
No procedures
2.4
18.0
189
1027
Y96.8
ICD-10 Finland
Other type of accident
+∞
17.8
17
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.1
17.5
83
303
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
17.5
81
292
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
17.3
126
577
S18
ICPC
Laceration/cut
2.2
17.2
270
1724
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
17.2
107
453
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
6.9
17.2
27
41
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
17.2
56
161
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.1
17.0
49
129
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
16.8
179
973
N02AX02
ATC
tramadol; systemic, rectal
2.2
16.6
246
1529
A41.9
ICD-10 Finland
Sepsis, unspecified
5.5
16.5
33
64
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
16.3
102
432
A10AB05
ATC
insulin aspart; parenteral
3.4
16.3
64
208
A01
ICPC
Pain general/multiple sites
3.1
16.2
76
275
T84.62
ICD-10 Finland
Osteitis associated with dental implants
31.2
16.2
21
7
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
31.2
16.2
21
7
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
16.2
155
803
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
16.1
182
1011
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
6.0
16.0
29
51
N03AX12
ATC
[U] gabapentin; oral
2.6
15.9
107
470
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
15.9
242
1513
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.2
15.8
24
35
C01CA24
ATC
epinephrine; parenteral
3.5
15.7
58
181
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.1
15.7
45
118
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
15.6
76
281
SPAT1262
SPAT
Handing over of treatment supplies
2.6
15.5
107
476
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
15.3
93
388
A28
ICPC
Limited function/disability NOS
2.6
15.2
104
460
N03AX09
ATC
lamotrigine; oral
3.9
15.1
46
126
SPAT1254
SPAT
Administration of medicine
2.6
14.9
97
418
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
19.1
14.8
22
12
N05AH04
ATC
quetiapine; oral
2.4
14.8
128
631
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.3
14.7
59
194
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
14.6
47
134
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
14.5
93
398
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
14.4
33
72
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
14.1
62
216
S91.3
ICD-10 Finland
Open wound of other parts of foot
4.8
14.0
32
70
SPAT1216
SPAT
Assessment of functional ability
2.6
13.9
90
386
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.5
13.9
23
37
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.7
13.8
82
337
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
13.7
131
671
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.9
13.6
42
116
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
13.5
90
391
RD211, ,
NOMESCO Finland
4.1
13.5
38
98
C03CA01
ATC
furosemide; systemic
2.2
13.5
151
826
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
13.4
227
1449
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.3
13.4
54
178
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
13.4
130
670
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
10.5
13.1
25
25
H02AB06
ATC
prednisolone; systemic
2.0
13.1
255
1709
N03AX16
ATC
[U] pregabalin
2.2
13.1
134
706
P19
ICPC
Drug abuse
23.3
13.0
18
8
SPAT1263
SPAT
Sampling
2.0
13.0
230
1489
A10AE05
ATC
insulin detemir; parenteral
3.6
12.9
44
130
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.7
12.9
75
304
Z50.1
ICD-10 Finland
Other physical therapy
3.8
12.9
40
111
S03.0
ICD-10 Finland
Dislocation of jaw
16.0
12.7
20
13
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
12.5
38
104
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
12.3
119
610
A10AE04
ATC
insulin glargine; parenteral
2.7
12.3
71
287
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
12.3
175
1043
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.2
12.3
50
166
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
12.2
99
470
A29
ICPC
General symptom/complaint other
2.5
12.1
89
404
J01MA02
ATC
ciprofloxacin; systemic
2.0
12.1
204
1289
R50.9
ICD-10 Finland
Fever, unspecified
2.4
11.9
97
462
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
6.0
11.9
21
36
Z00.0
ICD-10 Finland
General medical examination
2.2
11.8
119
619
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
11.8
80
350
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.7
11.7
22
40
SPAT1310
SPAT
Counselling related to known health issue
2.0
11.7
178
1082
P01AB01
ATC
metronidazole; oral, rectal
2.0
11.7
219
1431
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.1
11.7
52
182
Z72.8
ICD-10 Finland
Other problems related to lifestyle
66.6
11.7
13
*
J01MA12
ATC
levofloxacin; systemic
2.3
11.6
104
515
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
11.6
133
728
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.3
11.5
46
151
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
11.4
115
598
N05AA02
ATC
levomepromazine; systemic
3.9
11.2
33
88
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
14.3
11.0
18
13
SPAT1252
SPAT
Overall medication plan or its review
3.2
11.0
46
155
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
44.4
11.0
13
*
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
15.9
10.9
17
11
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
10.9
69
292
R51.80
ICD-10 Finland
Headache
2.2
10.8
109
567
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.9
10.7
291
2128
N05AH03
ATC
olanzapine; systemic
3.0
10.7
50
180
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.6
10.6
36
106
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
10.4
10.6
20
20
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.4
10.4
26
61
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.3
10.4
21
41
N05AD01
ATC
haloperidol; systemic
4.7
10.3
24
53
SPAT1260
SPAT
Consultation of another employee
2.2
10.3
104
539
P29
ICPC
Psychological sympt/compl other
2.7
10.3
61
249
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
10.3
148
876
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
10.3
378
3035
EBA00
NOMESCO Finland
Extraction of tooth
1.9
10.3
204
1344
ZXD05
NOMESCO Finland
Urgent procedure
1.9
10.3
162
990
WZC30
NOMESCO Finland
Teaching
2.2
10.2
97
491
WX872
NOMESCO Finland
Intensive care
3.4
10.2
37
114
P76
ICPC
Depressive disorder
2.8
10.1
54
209
N05CF01
ATC
zopiclone; oral
1.9
10.1
167
1036
K02.2
ICD-10 Finland
Caries of cementum
3.6
10.1
34
100
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
10.0
134
772
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.0
10.0
134
773
N05AX08
ATC
risperidone; systemic
2.7
9.9
57
229
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.1
9.9
21
43
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
9.8
108
578
WX110
NOMESCO Finland
Infiltration anesthesia
2.0
9.7
374
3014
P99
ICPC
Psychological disorders other
4.0
9.6
28
74
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
11.7
9.6
17
15
N05AX12
ATC
aripiprazole; systemic
3.5
9.6
33
98
K90
ICPC
Stroke/cerebrovascular accident
4.9
9.6
21
44
N02BE01
ATC
paracetamol; systemic, rectal
2.8
9.6
452
3932
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.4
9.6
22
31
L89
ICD-10 Finland
Decubitus ulcer and pressure area
7.4
9.6
22
31
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
9.6
61
258
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.0
9.5
27
70
T87.4
ICD-10 Finland
Infection of amputation stump
101.9
9.4
10
*
XQ800
NOMESCO Finland
Prick test
2.9
9.4
46
170
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.1
9.4
39
131
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
9.4
47
176
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
9.3
45
165
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
9.3
60
256
TK800
NOMESCO Finland
Hemodialysis
5.2
9.2
19
38
AA1AD
NOMESCO Finland
CT of head and brain
1.9
9.1
147
900
N06AX11
ATC
mirtazapine; oral
1.8
9.0
185
1220
UKC02
NOMESCO Finland
Cystoscopy
2.2
9.0
86
435
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
24.5
8.9
12
5
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
8.9
139
840
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
8.9
87
445
R11
ICD-10 Finland
Nausea and vomiting
2.5
8.8
57
243
M79.6
ICD-10 Finland
Pain in limb
1.8
8.8
230
1629
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.9
8.7
19
25
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
8.7
59
257
A11CC03
ATC
alfacalcidol; systemic
4.5
8.7
21
48
B03XA02
ATC
darbepoetin alfa; parenteral
4.9
8.7
19
40
Z3231
NOMESCO Finland
Registered nurse
1.9
8.6
144
888
R06AE07
ATC
cetirizine; oral
1.8
8.6
222
1561
ZX120
NOMESCO Finland
Intravenous
2.5
8.6
58
252
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
8.5
192
1297
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.4
8.5
62
279
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.5
232
1656
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
28.1
8.5
11
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
8.5
145
901
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.8
8.4
19
41
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
3.8
8.4
26
72
SPAT1255
SPAT
Intravenous administration of medicine
2.9
8.4
39
140
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.4
8.3
30
92
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
8.3
122
720
EBB10
NOMESCO Finland
Insertion of dental implant
9.7
8.3
16
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
8.3
76
377
SPAT1097
SPAT
Recording of ECG
2.2
8.3
73
357
S06.0
ICD-10 Finland
Concussion
2.3
8.3
69
330
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
8.2
72
351
N02BF01
ATC
gabapentin; oral
2.4
8.2
61
277
SPAT1234
SPAT
Support of social functional capacity
3.4
8.2
30
93
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.7
8.2
19
42
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
8.2
24
64
X84
ICD-10 Finland
Intentional self-harm by unspecified means
33.9
8.1
10
*
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
6.5
8.1
20
32
A02BC02
ATC
pantoprazole; systemic
1.8
8.0
335
2680
T74.1
ICD-10 Finland
Physical abuse
4.4
8.0
20
47
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
8.0
227
1631
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.8
8.0
24
65
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.2
8.0
31
100
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
7.9
41
156
Y94.0
ICD-10 Finland
Accident at home
13.3
7.9
13
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
7.9
23
61
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
7.9
131
805
T90
ICPC
Diabetes non-insulin dependent
1.9
7.9
121
725
C07AB07
ATC
bisoprolol; oral
1.7
7.8
227
1637
SPAT1153
SPAT
Removal of sutures
1.8
7.8
154
995
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
7.8
43
169
R05
ICPC
Cough
1.8
7.8
136
848
SPAT1360
SPAT
Extensive global examination
2.9
7.6
37
136
R60.0
ICD-10 Finland
Localized oedema
2.2
7.6
70
348
Y94.8
ICD-10 Finland
Other leisure activity accident
9.1
7.6
15
17
S01.50
ICD-10 Finland
Open wound in oral cavity
10.3
7.6
14
14
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
7.6
49
209
WX892
NOMESCO Finland
Monitored bed care
2.6
7.6
43
172
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.3
7.5
29
93
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
7.5
120
727
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.5
7.5
26
78
N03AG01
ATC
valproic acid; systemic, rectal
2.7
7.5
40
155
E0000UV, ,
ATC
1.7
7.5
212
1515
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
6.6
7.5
18
28
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
7.4
47
198
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
7.4
43
174
NGQ20
NOMESCO Finland
Amputation of lower leg
11.1
7.3
13
12
C07AA05
ATC
propranolol; systemic
1.9
7.3
112
668
N07BB01
ATC
disulfiram; oral
3.0
7.3
32
111
Y96
ICD-10 Finland
Work-related condition
+∞
7.3
7
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
16.0
7.3
11
7
J01DB01
ATC
cefalexin; oral
2.0
7.2
412
3553
ECB00
NOMESCO Finland
Suture of gingiva
3.4
7.2
26
80
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.4
7.2
26
80
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
6.7
7.2
17
26
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
7.2
275
2120
L04AD02
ATC
tacrolimus; systemic
8.1
7.1
15
19
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
6.2
7.1
18
30
N05BA04
ATC
oxazepam; oral
1.8
7.1
138
885
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
7.1
58
275
P72
ICPC
Schizophrenia
4.3
7.1
18
43
S76
ICPC
Skin infection other
2.8
7.1
36
136
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.3
7.1
53
242
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
7.0
33
119
N02BF02
ATC
pregabalin; oral
2.6
7.0
41
166
SPAT1307
SPAT
Psychosocial counselling and guidance
2.6
7.0
41
166
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
7.0
79
425
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.4
6.9
25
77
S09
ICPC
Infected finger/toe
3.6
6.9
23
67
SPAT1167
SPAT
Insertion of urinary catheter
4.2
6.9
18
44
WX212
NOMESCO Finland
Femoral plexus blockade
4.2
6.9
18
44
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
6.8
100
588
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
22.9
6.7
9
*
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.3
6.7
52
241
R4180
NOMESCO Finland
Podiatric therapy
6.6
6.7
16
25
M05BX04
ATC
denosumab; parenteral
2.9
6.7
32
117
L03.9
ICD-10 Finland
Cellulitis, unspecified
5.6
6.7
18
33
N18.8
ICD-10 Finland
Other chronic renal failure
5.6
6.7
18
33
J01EA01
ATC
trimethoprim; systemic
1.8
6.7
124
784
P15
ICPC
Chronic alcohol abuse
3.4
6.6
23
69
R96
ICPC
Asthma
2.2
6.6
55
262
R5110, ,
SPAT
2.4
6.6
46
203
WX725
NOMESCO Finland
Noninvasive ventilation
2.7
6.6
36
141
SPAT1211
SPAT
Application of soft bandage
2.4
6.6
48
216
N03AX14
ATC
levetiracetam; systemic
3.9
6.6
19
50
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
6.6
54
256
N30.0
ICD-10 Finland
Acute cystitis
1.9
6.6
89
509
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
6.6
188
1336
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.2
6.6
12
12
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.2
6.6
26
85
N03AE01
ATC
clonazepam; systemic
2.8
6.5
33
124
E000001, ,
ATC
1.9
6.5
100
595
W19
ICD-10 Finland
Unspecified fall
2.2
6.5
54
257
X58
ICD-10 Finland
Exposure to other specified factors
1.9
6.5
83
465
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
6.5
110
675
J45.8
ICD-10 Finland
Mixed asthma
3.6
6.5
21
60
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
6.5
23
70
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.0
6.5
18
46
IHZ05, ,
SPAT
2.8
6.5
33
125
J01DA01
ATC
[U] cefalexin
1.6
6.5
298
2381
S01.0
ICD-10 Finland
Open wound of scalp
2.4
6.4
44
193
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.2
6.4
17
42
V03AE01
ATC
polystyrene sulfonate; oral
8.3
6.4
13
16
A41.8
ICD-10 Finland
Other specified sepsis
5.6
6.4
17
31
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
6.3
26
87
WX213
NOMESCO Finland
Lower leg blockade
11.2
6.3
11
10
ZXA05
NOMESCO Finland
Left side
1.8
6.3
111
689
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
18.3
6.3
9
5
Z72.2
ICD-10 Finland
Drug use
18.3
6.3
9
5
B01AB05
ATC
enoxaparin; parenteral
1.7
6.3
147
989
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.4
6.3
44
195
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
+∞
6.3
6
*
IFC01, ,
SPAT
+∞
6.3
6
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
7.2
6.3
14
20
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.2
6.3
52
248
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
6.3
19
52
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.1
6.2
18
36
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.1
6.2
63
325
R03BA08
ATC
ciclesonide; inhalant
2.3
6.1
48
223
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
6.1
230
1740
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.1
179
1275
R1250
NOMESCO Finland
Evaluation of functional capability
3.7
6.1
19
53
S06
ICPC
Rash localized
2.7
6.1
33
129
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
6.1
34
135
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
6.8
6.1
14
21
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
6.8
6.1
14
21
WX704
NOMESCO Finland
Intubation
2.3
6.1
46
211
F10.25
ICD-10 Finland
Alcohol dependence continuous use
5.3
6.1
17
33
K05.31
ICD-10 Finland
Periodontitis pronounced
2.2
6.1
55
272
M54.5
ICD-10 Finland
Low back pain
1.6
6.0
182
1304
127
Kela drug reimbursment
Transplant complication
5.7
6.0
16
29
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.4
6.0
43
192
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Emergency Room Visit
ER [9203]
ER [9203]
8.7e-01
1.2e+00
2.2e+00
6.2e+00
2.0e+00
1.3e+00
1.1e+00
cases:61.13%
controls:39.72%
cases:34.21%
controls:13.66%
cases:12.55%
controls:1.50%
cases:33.81%
controls:0.10%
cases:10.75%
controls:1.68%
cases:30.36%
controls:10.74%
cases:49.62%
controls:24.85%
302
1962
192
2978
169
675
325
4265
62
74
432
4866
167
5
327
4935
53
83
440
4851
143
517
328
4295
197
1031
200
3118
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
1.2e+00
1.5e+00
3.0e+00
—
2.8e+00
2.4e+00
1.6e+00
cases:9.11%
controls:2.87%
cases:4.86%
controls:1.17%
cases:2.83%
controls:0.14%
—
—
cases:4.06%
controls:0.26%
cases:7.86%
controls:0.77%
cases:10.33%
controls:2.19%
45
142
449
4798
24
58
470
4882
14
7
480
4933
—
20
13
473
4921
37
37
434
4775
41
91
356
4058
Internal Medicine
11 [38004456]
11 [38004456]
7.9e-01
1.1e+00
1.6e+00
4.7e+00
2.0e+00
1.1e+00
9.8e-01
cases:37.85%
controls:21.70%
cases:23.89%
controls:9.11%
cases:5.26%
controls:1.13%
cases:11.34%
controls:0.12%
cases:9.74%
controls:1.38%
cases:19.75%
controls:7.71%
cases:34.01%
controls:16.15%
187
1072
307
3868
118
450
376
4490
26
56
468
4884
56
6
438
4934
48
68
445
4866
93
371
378
4441
135
670
262
3479
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
1.1e+00
1.8e+00
2.8e+00
—
2.6e+00
2.2e+00
1.6e+00
cases:2.83%
controls:0.97%
cases:3.24%
controls:0.55%
cases:2.02%
controls:0.12%
—
—
cases:1.62%
controls:0.12%
cases:2.97%
controls:0.33%
cases:5.54%
controls:1.21%
14
48
480
4892
16
27
478
4913
10
6
484
4934
—
8
6
485
4928
14
16
457
4796
22
50
375
4099
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
N02AB03 [21604272]
2.3e+00
2.2e+00
2.7e+00
—
2.3e+00
2.0e+00
—
cases:1.82%
controls:0.18%
cases:1.42%
controls:0.16%
cases:1.42%
controls:0.10%
—
—
cases:1.22%
controls:0.12%
cases:1.70%
controls:0.23%
—
—
9
9
485
4931
7
8
487
4932
7
5
487
4935
—
6
6
487
4928
8
11
463
4801
—
Nephrology
39 [38004479]
39 [38004479]
1.6e+00
1.6e+00
2.4e+00
—
2.3e+00
1.9e+00
1.6e+00
cases:4.86%
controls:1.03%
cases:4.45%
controls:0.89%
cases:2.23%
controls:0.20%
—
—
cases:3.04%
controls:0.32%
cases:5.31%
controls:0.81%
cases:4.79%
controls:1.04%
24
51
470
4889
22
44
472
4896
11
10
483
4930
—
15
16
478
4918
25
39
446
4773
19
43
378
4106
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
1.6e+00
1.5e+00
2.3e+00
—
2.3e+00
2.1e+00
1.4e+00
cases:7.49%
controls:1.58%
cases:5.26%
controls:1.28%
cases:3.44%
controls:0.34%
—
—
cases:3.45%
controls:0.34%
cases:7.43%
controls:0.98%
cases:11.84%
controls:3.09%
37
78
457
4862
26
63
468
4877
17
17
477
4923
—
17
17
476
4917
35
47
436
4765
47
128
350
4021
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
1.1e+00
1.1e+00
2.8e+00
1.0e+50
3.1e+00
1.8e+00
1.3e+00
cases:4.86%
controls:1.70%
cases:3.44%
controls:1.13%
cases:2.23%
controls:0.14%
cases:2.02%
controls:0.00%
cases:3.45%
controls:0.16%
cases:5.10%
controls:0.87%
cases:5.79%
controls:1.66%
24
84
470
4856
17
56
477
4884
11
7
483
4933
10
0
484
4940
17
8
476
4926
24
42
447
4770
23
69
374
4080
Vascular Surgery
77 [38004496]
77 [38004496]
9.6e-01
1.2e+00
3.1e+00
1.0e+50
2.6e+00
1.8e+00
1.3e+00
cases:8.50%
controls:3.44%
cases:4.86%
controls:1.52%
cases:2.63%
controls:0.12%
cases:2.43%
controls:0.00%
cases:2.43%
controls:0.18%
cases:7.43%
controls:1.27%
cases:12.59%
controls:3.93%
42
170
452
4770
24
75
470
4865
13
6
481
4934
12
0
482
4940
12
9
481
4925
35
61
436
4751
50
163
347
3986
Dentistry
C5 [903277]
C5 [903277]
1.3e+00
1.8e+00
1.7e+00
1.0e+50
3.8e+00
2.6e+00
1.4e+00
cases:7.49%
controls:2.19%
cases:3.64%
controls:0.63%
cases:1.01%
controls:0.18%
cases:14.98%
controls:0.00%
cases:4.46%
controls:0.10%
cases:8.07%
controls:0.67%
cases:8.82%
controls:2.29%
37
108
457
4832
18
31
476
4909
5
9
489
4931
74
0
420
4940
22
5
471
4929
38
32
433
4780
35
95
362
4054
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
1.2e+00
1.0e+00
2.9e+00
—
2.6e+00
1.9e+00
1.0e+00
cases:7.49%
controls:2.43%
cases:3.24%
controls:1.21%
cases:1.82%
controls:0.10%
—
—
cases:1.62%
controls:0.12%
cases:5.52%
controls:0.87%
cases:10.83%
controls:4.19%
37
120
457
4820
16
60
478
4880
9
5
485
4935
—
8
6
485
4928
26
42
445
4770
43
174
354
3975
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
2.5e+00
2.9e+00
—
1.0e+50
—
3.1e+00
2.0e+00
cases:3.64%
controls:0.30%
cases:2.83%
controls:0.16%
—
—
cases:1.42%
controls:0.00%
—
—
cases:3.18%
controls:0.15%
cases:2.02%
controls:0.27%
18
15
476
4925
14
8
480
4932
—
7
0
487
4940
—
15
7
456
4805
8
11
389
4138
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
9.2e-01
1.0e+00
2.5e+00
1.0e+50
3.2e+00
1.8e+00
1.0e+00
cases:8.10%
controls:3.40%
cases:4.25%
controls:1.56%
cases:1.42%
controls:0.12%
cases:1.62%
controls:0.00%
cases:3.04%
controls:0.12%
cases:7.64%
controls:1.31%
cases:11.59%
controls:4.39%
40
168
454
4772
21
77
473
4863
7
6
487
4934
8
0
486
4940
15
6
478
4928
36
63
435
4749
46
182
351
3967
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.4e+00
1.1e+00
1.9e+00
1.0e+50
2.7e+00
1.7e+00
1.3e+00
cases:29.55%
controls:9.70%
cases:9.72%
controls:3.44%
cases:2.43%
controls:0.36%
cases:1.42%
controls:0.00%
cases:5.68%
controls:0.39%
cases:9.98%
controls:2.04%
cases:14.11%
controls:4.24%
146
479
348
4461
48
170
446
4770
12
18
482
4922
7
0
487
4940
28
19
465
4915
47
98
424
4714
56
176
341
3973
darbepoetin alfa; parenteral
B03XA02 [21601134]
B03XA02 [21601134]
2.6e+00
2.7e+00
—
—
—
2.2e+00
2.2e+00
cases:1.62%
controls:0.12%
cases:1.82%
controls:0.12%
—
—
—
—
—
—
cases:1.49%
controls:0.17%
cases:2.27%
controls:0.27%
8
6
486
4934
9
6
485
4934
—
—
—
7
8
464
4804
9
11
388
4138
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
2.0e+00
2.3e+00
—
—
1.0e+50
3.2e+00
2.2e+00
cases:3.24%
controls:0.47%
cases:2.63%
controls:0.26%
—
—
—
—
cases:1.62%
controls:0.00%
cases:4.25%
controls:0.19%
cases:6.55%
controls:0.80%
16
23
478
4917
13
13
481
4927
—
—
8
0
485
4934
20
9
451
4803
26
33
371
4116
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.6e-01
7.1e-01
1.4e+00
4.0e+00
1.6e+00
7.8e-01
6.3e-01
cases:48.99%
controls:40.22%
cases:43.12%
controls:27.25%
cases:18.22%
controls:5.18%
cases:17.81%
controls:0.38%
cases:21.70%
controls:5.31%
cases:45.65%
controls:27.70%
cases:73.30%
controls:59.46%
242
1987
252
2953
213
1346
281
3594
90
256
404
4684
88
19
406
4921
107
262
386
4672
215
1333
256
3479
291
2467
106
1682
General Practice
1 [38004446]
1 [38004446]
8.9e-01
1.3e+00
2.4e+00
1.0e+50
2.3e+00
1.3e+00
1.1e+00
cases:32.59%
controls:16.50%
cases:19.84%
controls:6.38%
cases:7.09%
controls:0.71%
cases:11.94%
controls:0.00%
cases:9.53%
controls:1.09%
cases:18.68%
controls:6.15%
cases:35.77%
controls:15.67%
161
815
333
4125
98
315
396
4625
35
35
459
4905
59
0
435
4940
47
54
446
4880
88
296
383
4516
142
650
255
3499
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
4.4e-01
8.5e-01
1.0e+00
3.6e+00
1.1e+00
9.5e-01
1.1e+00
cases:19.03%
controls:13.18%
cases:18.02%
controls:8.60%
cases:7.89%
controls:2.91%
cases:5.87%
controls:0.16%
cases:9.33%
controls:3.26%
cases:19.11%
controls:8.37%
cases:39.04%
controls:18.12%
94
651
400
4289
89
425
405
4515
39
144
455
4796
29
8
465
4932
46
161
447
4773
90
403
381
4409
155
752
242
3397
Laceration/cut
S18 [2002000983]
S18 [2002000983]
8.6e-01
1.0e+00
2.1e+00
—
2.7e+00
1.5e+00
9.7e-01
cases:22.06%
controls:10.73%
cases:10.32%
controls:4.01%
cases:3.04%
controls:0.38%
—
—
cases:6.29%
controls:0.47%
cases:14.23%
controls:3.68%
cases:28.72%
controls:13.23%
109
530
385
4410
51
198
443
4742
15
19
479
4921
—
31
23
462
4911
67
177
404
4635
114
549
283
3600
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
1.1e+00
1.7e+00
1.7e+00
—
1.8e+00
1.4e+00
1.3e+00
cases:5.47%
controls:1.88%
cases:6.28%
controls:1.19%
cases:2.02%
controls:0.36%
—
—
cases:2.03%
controls:0.32%
cases:4.67%
controls:1.23%
cases:10.08%
controls:3.06%
27
93
467
4847
31
59
463
4881
10
18
484
4922
—
10
16
483
4918
22
59
449
4753
40
127
357
4022
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
7.6e-01
1.5e+00
2.0e+00
1.0e+50
2.3e+00
1.4e+00
1.1e+00
cases:12.15%
controls:6.09%
cases:11.54%
controls:2.91%
cases:3.24%
controls:0.45%
cases:3.85%
controls:0.00%
cases:4.67%
controls:0.49%
cases:9.98%
controls:2.68%
cases:24.18%
controls:9.64%
60
301
434
4639
57
144
437
4796
16
22
478
4918
19
0
475
4940
23
24
470
4910
47
129
424
4683
96
400
301
3749
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
E10.7 [45571655]
1.2e+00
1.3e+00
2.6e+00
1.0e+50
2.3e+00
1.5e+00
9.5e-01
cases:2.63%
controls:0.77%
cases:2.23%
controls:0.61%
cases:1.62%
controls:0.12%
cases:1.21%
controls:0.00%
cases:1.62%
controls:0.16%
cases:2.76%
controls:0.62%
cases:2.52%
controls:0.99%
13
38
481
4902
11
30
483
4910
8
6
486
4934
6
0
488
4940
8
8
485
4926
13
30
458
4782
10
41
387
4108
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.8e-01
5.1e-01
1.5e+00
4.0e+00
1.6e+00
6.6e-01
4.7e-01
cases:52.23%
controls:45.12%
cases:43.72%
controls:31.74%
cases:19.84%
controls:5.28%
cases:15.99%
controls:0.34%
cases:21.70%
controls:5.13%
cases:46.50%
controls:30.92%
cases:71.79%
controls:61.32%
258
2229
236
2711
216
1568
278
3372
98
261
396
4679
79
17
415
4923
107
253
386
4681
219
1488
252
3324
285
2544
112
1605
Inpatient Hospital
21 [8717]
21 [8717]
7.1e-01
1.1e+00
2.0e+00
—
2.5e+00
1.2e+00
1.0e+00
cases:47.17%
controls:30.53%
cases:25.91%
controls:10.12%
cases:9.31%
controls:1.36%
—
—
cases:12.17%
controls:1.07%
cases:21.87%
controls:7.54%
cases:33.00%
controls:14.70%
233
1508
261
3432
128
500
366
4440
46
67
448
4873
—
60
53
433
4881
103
363
368
4449
131
610
266
3539
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
3.4e-01
4.9e-01
1.3e+00
3.9e+00
1.5e+00
6.8e-01
5.0e-01
cases:52.63%
controls:44.09%
cases:47.57%
controls:35.65%
cases:20.04%
controls:6.44%
cases:18.02%
controls:0.45%
cases:22.11%
controls:6.14%
cases:53.08%
controls:36.39%
cases:76.07%
controls:65.82%
260
2178
234
2762
235
1761
259
3179
99
318
395
4622
89
22
405
4918
109
303
384
4631
250
1751
221
3061
302
2731
95
1418
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
1.2e+00
1.3e+00
2.0e+00
—
1.9e+00
1.1e+00
1.2e+00
cases:9.11%
controls:3.04%
cases:6.68%
controls:1.98%
cases:2.43%
controls:0.34%
—
—
cases:3.04%
controls:0.45%
cases:6.37%
controls:2.14%
cases:12.85%
controls:4.43%
45
150
449
4790
33
98
461
4842
12
17
482
4923
—
15
22
478
4912
30
103
441
4709
51
184
346
3965
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
7.2e-01
1.5e+00
1.5e+00
1.0e+50
1.8e+00
1.7e+00
1.3e+00
cases:14.37%
controls:7.55%
cases:10.73%
controls:2.49%
cases:2.63%
controls:0.61%
cases:1.42%
controls:0.00%
cases:3.25%
controls:0.55%
cases:12.10%
controls:2.54%
cases:21.41%
controls:7.01%
71
373
423
4567
53
123
441
4817
13
30
481
4910
7
0
487
4940
16
27
477
4907
57
122
414
4690
85
291
312
3858
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
3.2e-01
4.8e-01
1.3e+00
3.8e+00
1.4e+00
6.4e-01
4.8e-01
cases:52.63%
controls:44.62%
cases:47.77%
controls:36.17%
cases:20.24%
controls:6.58%
cases:17.00%
controls:0.45%
cases:22.11%
controls:6.32%
cases:52.44%
controls:36.82%
cases:76.07%
controls:66.38%
260
2204
234
2736
236
1787
258
3153
100
325
394
4615
84
22
410
4918
109
312
384
4622
247
1772
224
3040
302
2754
95
1395
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
1.6e+00
1.6e+00
1.0e+50
1.0e+50
1.0e+50
3.0e+00
2.3e+00
cases:3.44%
controls:0.75%
cases:1.62%
controls:0.32%
cases:1.21%
controls:0.00%
cases:1.01%
controls:0.00%
cases:2.64%
controls:0.00%
cases:4.25%
controls:0.23%
cases:6.55%
controls:0.70%
17
37
477
4903
8
16
486
4924
6
0
488
4940
5
0
489
4940
13
0
480
4934
20
11
451
4801
26
29
371
4120
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
1.3e+00
2.0e+00
—
1.0e+50
2.6e+00
1.3e+00
1.2e+00
cases:5.67%
controls:1.60%
cases:6.28%
controls:0.89%
—
—
cases:1.82%
controls:0.00%
cases:1.62%
controls:0.12%
cases:3.82%
controls:1.12%
cases:10.83%
controls:3.59%
28
79
466
4861
31
44
463
4896
—
9
0
485
4940
8
6
485
4928
18
54
453
4758
43
149
354
4000
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
9.1e-01
9.1e-01
2.2e+00
1.0e+50
2.4e+00
1.3e+00
6.2e-01
cases:10.12%
controls:4.33%
cases:4.45%
controls:1.84%
cases:2.23%
controls:0.26%
cases:1.21%
controls:0.00%
cases:2.84%
controls:0.26%
cases:4.67%
controls:1.27%
cases:11.34%
controls:6.41%
50
214
444
4726
22
91
472
4849
11
13
483
4927
6
0
488
4940
14
13
479
4921
22
61
449
4751
45
266
352
3883
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
2.4e+00
2.9e+00
—
1.0e+50
—
3.0e+00
1.6e+00
cases:4.25%
controls:0.38%
cases:2.83%
controls:0.16%
—
—
cases:3.44%
controls:0.00%
—
—
cases:2.76%
controls:0.15%
cases:2.02%
controls:0.43%
21
19
473
4921
14
8
480
4932
—
17
0
477
4940
—
13
7
458
4805
8
18
389
4131
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
1.3e+00
2.0e+00
—
1.0e+50
2.6e+00
1.2e+00
1.1e+00
cases:5.87%
controls:1.64%
cases:6.28%
controls:0.91%
—
—
cases:1.82%
controls:0.00%
cases:1.62%
controls:0.12%
cases:3.82%
controls:1.14%
cases:10.58%
controls:3.62%
29
81
465
4859
31
45
463
4895
—
9
0
485
4940
8
6
485
4928
18
55
453
4757
42
150
355
3999
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
1.3e+00
2.0e+00
—
1.0e+50
2.6e+00
1.2e+00
1.2e+00
cases:5.67%
controls:1.64%
cases:6.28%
controls:0.91%
—
—
cases:1.82%
controls:0.00%
cases:1.62%
controls:0.12%
cases:3.82%
controls:1.16%
cases:11.08%
controls:3.69%
28
81
466
4859
31
45
463
4895
—
9
0
485
4940
8
6
485
4928
18
56
453
4756
44
153
353
3996
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
5.0e-01
1.1e+00
2.3e+00
—
2.0e+00
1.8e+00
1.0e+00
cases:2.63%
controls:1.62%
cases:3.44%
controls:1.19%
cases:1.21%
controls:0.12%
—
—
cases:1.22%
controls:0.16%
cases:5.31%
controls:0.96%
cases:8.06%
controls:2.99%
13
80
481
4860
17
59
477
4881
6
6
488
4934
—
6
8
487
4926
25
46
446
4766
32
124
365
4025
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
39480-9 [3038515]
2.3e+00
2.4e+00
—
1.0e+50
—
1.6e+00
1.8e+00
cases:2.83%
controls:0.28%
cases:2.63%
controls:0.24%
—
—
cases:1.01%
controls:0.00%
—
—
cases:2.12%
controls:0.42%
cases:4.79%
controls:0.80%
14
14
480
4926
13
12
481
4928
—
5
0
489
4940
—
10
20
461
4792
19
33
378
4116
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
2519-7 [3008037]
2.3e+00
2.4e+00
—
1.0e+50
—
1.6e+00
1.9e+00
cases:2.83%
controls:0.30%
cases:2.63%
controls:0.24%
—
—
cases:1.01%
controls:0.00%
—
—
cases:2.12%
controls:0.42%
cases:5.79%
controls:0.92%
14
15
480
4925
13
12
481
4928
—
5
0
489
4940
—
10
20
461
4792
23
38
374
4111
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.6e-01
7.2e-01
9.9e-01
3.1e+00
1.3e+00
7.6e-01
8.3e-01
cases:35.02%
controls:25.34%
cases:29.55%
controls:16.96%
cases:8.91%
controls:3.52%
cases:4.05%
controls:0.18%
cases:10.55%
controls:3.10%
cases:29.51%
controls:16.44%
cases:58.44%
controls:38.08%
173
1252
321
3688
146
838
348
4102
44
174
450
4766
20
9
474
4931
52
153
441
4781
139
791
332
4021
232
1580
165
2569
Outpatient Visit
OP [9202]
OP [9202]
7.7e-01
6.6e-01
7.4e-01
3.9e+00
1.2e+00
8.5e-01
4.1e-01
cases:89.88%
controls:80.43%
cases:72.27%
controls:57.41%
cases:22.06%
controls:11.92%
cases:21.86%
controls:0.55%
cases:32.25%
controls:12.14%
cases:75.16%
controls:56.36%
cases:92.19%
controls:88.65%
444
3973
50
967
357
2836
137
2104
109
589
385
4351
108
27
386
4913
159
599
334
4335
354
2712
117
2100
366
3678
31
471
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
4.0e-01
7.1e-01
1.4e+00
3.3e+00
1.0e+00
6.7e-01
6.0e-01
cases:28.95%
controls:21.38%
cases:21.46%
controls:11.80%
cases:6.48%
controls:1.62%
cases:3.24%
controls:0.12%
cases:5.27%
controls:1.99%
cases:19.53%
controls:11.01%
cases:44.84%
controls:30.87%
143
1056
351
3884
106
583
388
4357
32
80
462
4860
16
6
478
4934
26
98
467
4836
92
530
379
4282
178
1281
219
2868
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
1.2e+00
1.5e+00
1.6e+00
—
1.4e+00
1.5e+00
1.1e+00
cases:8.70%
controls:2.73%
cases:7.69%
controls:1.90%
cases:3.04%
controls:0.65%
—
—
cases:2.23%
controls:0.59%
cases:7.86%
controls:1.95%
cases:13.10%
controls:4.82%
43
135
451
4805
38
94
456
4846
15
32
479
4908
—
11
29
482
4905
37
94
434
4718
52
200
345
3949
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
2.3e+00
—
—
—
—
2.8e+00
3.0e+00
cases:2.02%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.10%
cases:3.27%
controls:0.17%
10
10
484
4930
—
—
—
—
8
5
463
4807
13
7
384
4142
calcium carbonate; oral
A12AA04 [21600863]
A12AA04 [21600863]
1.8e+00
1.9e+00
—
—
—
2.0e+00
2.4e+00
cases:2.02%
controls:0.34%
cases:1.82%
controls:0.26%
—
—
—
—
—
—
cases:1.49%
controls:0.21%
cases:2.77%
controls:0.27%
10
17
484
4923
9
13
485
4927
—
—
—
7
10
464
4802
11
11
386
4138
calcium carbonate
A02AC01 [21600065]
A02AC01 [21600065]
1.8e+00
1.9e+00
—
—
—
2.0e+00
2.4e+00
cases:2.02%
controls:0.34%
cases:1.82%
controls:0.26%
—
—
—
—
—
—
cases:1.49%
controls:0.21%
cases:2.77%
controls:0.27%
10
17
484
4923
9
13
485
4927
—
—
—
7
10
464
4802
11
11
386
4138
Dietary counselling and surveillance
Z71.3 [45552101]
Z71.3 [45552101]
1.5e+00
2.2e+00
—
—
—
2.5e+00
2.0e+00
cases:3.24%
controls:0.77%
cases:1.62%
controls:0.18%
—
—
—
—
—
—
cases:1.91%
controls:0.17%
cases:2.52%
controls:0.36%
16
38
478
4902
8
9
486
4931
—
—
—
9
8
462
4804
10
15
387
4134
Simple examination of mouth
SAA01 [2001310274]
SAA01 [2001310274]
4.9e-01
4.8e-01
8.6e-01
3.9e+00
1.1e+00
7.2e-01
5.3e-01
cases:42.91%
controls:31.48%
cases:21.26%
controls:14.27%
cases:4.86%
controls:2.11%
cases:6.48%
controls:0.14%
cases:5.27%
controls:1.84%
cases:24.84%
controls:13.86%
cases:49.62%
controls:36.66%
212
1555
282
3385
105
705
389
4235
24
104
470
4836
32
7
462
4933
26
91
467
4843
117
667
354
4145
197
1521
200
2628
General Surgery
2 [38004447]
2 [38004447]
8.3e-01
1.1e+00
1.7e+00
1.0e+50
1.9e+00
1.3e+00
1.1e+00
cases:27.13%
controls:13.93%
cases:11.54%
controls:4.25%
cases:3.44%
controls:0.67%
cases:6.88%
controls:0.00%
cases:3.25%
controls:0.49%
cases:10.83%
controls:3.12%
cases:22.17%
controls:8.34%
134
688
360
4252
57
210
437
4730
17
33
477
4907
34
0
460
4940
16
24
477
4910
51
150
420
4662
88
346
309
3803
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
1.1e+00
1.4e+00
1.8e+00
—
1.4e+00
1.4e+00
8.7e-01
cases:12.96%
controls:4.80%
cases:10.73%
controls:3.02%
cases:5.47%
controls:0.97%
—
—
cases:4.26%
controls:1.03%
cases:11.68%
controls:3.30%
cases:13.10%
controls:5.95%
64
237
430
4703
53
149
441
4791
27
48
467
4892
—
21
51
472
4883
55
159
416
4653
52
247
345
3902
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
6.3e-01
7.9e-01
8.9e-01
2.7e+00
1.3e+00
7.9e-01
7.9e-01
cases:58.50%
controls:43.00%
cases:38.66%
controls:22.23%
cases:10.32%
controls:4.51%
cases:2.02%
controls:0.14%
cases:13.59%
controls:4.07%
cases:39.70%
controls:23.05%
cases:68.26%
controls:49.51%
289
2124
205
2816
191
1098
303
3842
51
223
443
4717
10
7
484
4933
67
201
426
4733
187
1109
284
3703
271
2054
126
2095
Psychiatry
26 [38004469]
26 [38004469]
1.2e+00
1.1e+00
1.4e+00
—
1.7e+00
1.4e+00
1.1e+00
cases:19.43%
controls:6.90%
cases:11.34%
controls:4.15%
cases:6.48%
controls:1.76%
—
—
cases:8.52%
controls:1.70%
cases:14.65%
controls:3.91%
cases:19.65%
controls:7.59%
96
341
398
4599
56
205
438
4735
32
87
462
4853
—
42
84
451
4850
69
188
402
4624
78
315
319
3834
General medical examination
Z00.0 [45585791]
Z00.0 [45585791]
9.9e-01
1.5e+00
—
—
2.2e+00
2.3e+00
8.7e-01
cases:8.50%
controls:3.34%
cases:4.45%
controls:0.99%
—
—
—
—
cases:1.22%
controls:0.14%
cases:6.37%
controls:0.71%
cases:7.30%
controls:3.21%
42
165
452
4775
22
49
472
4891
—
—
6
7
487
4927
30
34
441
4778
29
133
368
4016
Orthopedic Surgery
20 [38004465]
20 [38004465]
7.0e-01
9.8e-01
1.6e+00
1.0e+50
2.4e+00
1.3e+00
7.4e-01
cases:27.33%
controls:15.71%
cases:14.98%
controls:6.19%
cases:5.06%
controls:1.09%
cases:6.48%
controls:0.00%
cases:8.72%
controls:0.83%
cases:17.62%
controls:5.59%
cases:31.23%
controls:17.88%
135
776
359
4164
74
306
420
4634
25
54
469
4886
32
0
462
4940
43
41
450
4893
83
269
388
4543
124
742
273
3407
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
2.6e+00
2.6e+00
—
—
—
2.5e+00
—
cases:1.62%
controls:0.12%
cases:1.62%
controls:0.12%
—
—
—
—
—
—
cases:1.49%
controls:0.12%
—
—
8
6
486
4934
8
6
486
4934
—
—
—
7
6
464
4806
—
Inpatient Visit
IP [9201]
IP [9201]
6.3e-01
1.1e+00
1.7e+00
—
2.1e+00
1.2e+00
8.6e-01
cases:8.30%
controls:4.62%
cases:10.12%
controls:3.70%
cases:1.82%
controls:0.32%
—
—
cases:3.04%
controls:0.36%
cases:11.68%
controls:3.78%
cases:26.20%
controls:13.02%
41
228
453
4712
50
183
444
4757
9
16
485
4924
—
15
18
478
4916
55
182
416
4630
104
540
293
3609
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
9.5e-01
1.0e+00
1.6e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:9.11%
controls:3.72%
cases:5.47%
controls:2.09%
cases:2.02%
controls:0.40%
—
—
cases:2.64%
controls:0.53%
cases:6.16%
controls:1.79%
cases:9.32%
controls:3.18%
45
184
449
4756
27
103
467
4837
10
20
484
4920
—
13
26
480
4908
29
86
442
4726
37
132
360
4017
Infectious Disease
44 [38004484]
44 [38004484]
1.2e+00
1.6e+00
2.3e+00
—
2.3e+00
1.4e+00
1.2e+00
cases:6.07%
controls:1.98%
cases:3.85%
controls:0.81%
cases:1.21%
controls:0.12%
—
—
cases:1.01%
controls:0.10%
cases:3.40%
controls:0.87%
cases:8.31%
controls:2.75%
30
98
464
4842
19
40
475
4900
6
6
488
4934
—
5
5
488
4929
16
42
455
4770
33
114
364
4035
Outpatient Hospital
22 [8756]
22 [8756]
6.0e-01
8.8e-01
1.7e+00
—
2.3e+00
1.1e+00
1.0e+00
cases:38.87%
controls:25.95%
cases:17.21%
controls:7.91%
cases:4.86%
controls:0.95%
—
—
cases:6.09%
controls:0.67%
cases:14.23%
controls:5.07%
cases:22.67%
controls:9.35%
192
1282
302
3658
85
391
409
4549
24
47
470
4893
—
30
33
463
4901
67
244
404
4568
90
388
307
3761
Emergency Medicine
93 [38004510]
93 [38004510]
6.8e-01
1.1e+00
2.1e+00
1.0e+50
1.7e+00
1.1e+00
8.9e-01
cases:28.95%
controls:17.11%
cases:23.89%
controls:9.70%
cases:9.51%
controls:1.30%
cases:24.70%
controls:0.00%
cases:7.91%
controls:1.48%
cases:26.33%
controls:10.76%
cases:56.17%
controls:34.51%
143
845
351
4095
118
479
376
4461
47
64
447
4876
122
0
372
4940
39
73
454
4861
124
518
347
4294
223
1432
174
2717
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.2e-01
3.8e-01
1.2e+00
3.7e+00
1.2e+00
4.5e-01
5.9e-01
cases:36.64%
controls:31.66%
cases:36.23%
controls:28.06%
cases:17.00%
controls:5.61%
cases:11.13%
controls:0.32%
cases:16.43%
controls:5.57%
cases:40.34%
controls:30.03%
cases:70.03%
controls:56.52%
181
1564
313
3376
179
1386
315
3554
84
277
410
4663
55
16
439
4924
81
275
412
4659
190
1445
281
3367
278
2345
119
1804
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
8.9e-01
1.1e+00
1.6e+00
—
1.4e+00
1.5e+00
1.0e+00
cases:10.93%
controls:4.82%
cases:6.68%
controls:2.27%
cases:2.63%
controls:0.57%
—
—
cases:3.25%
controls:0.85%
cases:8.49%
controls:2.00%
cases:11.34%
controls:4.29%
54
238
440
4702
33
112
461
4828
13
28
481
4912
—
16
42
477
4892
40
96
431
4716
45
178
352
3971
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
3.3e-01
6.4e-01
1.5e+00
2.5e+00
1.6e+00
5.8e-01
6.2e-01
cases:18.42%
controls:13.95%
cases:16.19%
controls:9.21%
cases:6.88%
controls:1.62%
cases:1.21%
controls:0.10%
cases:7.91%
controls:1.70%
cases:15.71%
controls:9.41%
cases:36.78%
controls:23.89%
91
689
403
4251
80
455
414
4485
34
80
460
4860
6
5
488
4935
39
84
454
4850
74
453
397
4359
146
991
251
3158
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
1.0e+00
1.5e+00
1.8e+00
—
1.9e+00
1.3e+00
7.0e-01
cases:5.47%
controls:2.00%
cases:3.44%
controls:0.81%
cases:1.62%
controls:0.28%
—
—
cases:1.83%
controls:0.28%
cases:3.40%
controls:0.98%
cases:4.79%
controls:2.43%
27
99
467
4841
17
40
477
4900
8
14
486
4926
—
9
14
484
4920
16
47
455
4765
19
101
378
4048
epinephrine; parenteral
C01CA24 [21600303]
C01CA24 [21600303]
1.4e+00
2.1e+00
—
1.0e+50
1.0e+50
2.0e+00
1.9e+00
cases:4.86%
controls:1.26%
cases:5.26%
controls:0.65%
—
—
cases:1.21%
controls:0.00%
cases:1.22%
controls:0.00%
cases:4.46%
controls:0.64%
cases:8.56%
controls:1.40%
24
62
470
4878
26
32
468
4908
—
6
0
488
4940
6
0
487
4934
21
31
450
4781
34
58
363
4091
epinephrine
S01EA01 [21603673]
S01EA01 [21603673]
1.4e+00
2.1e+00
—
1.0e+50
1.0e+50
2.0e+00
1.9e+00
cases:4.86%
controls:1.26%
cases:5.26%
controls:0.65%
—
—
cases:1.21%
controls:0.00%
cases:1.22%
controls:0.00%
cases:4.46%
controls:0.64%
cases:8.56%
controls:1.40%
24
62
470
4878
26
32
468
4908
—
6
0
488
4940
6
0
487
4934
21
31
450
4781
34
58
363
4091
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
2.0e+00
2.3e+00
—
1.0e+50
—
1.7e+00
1.4e+00
cases:4.05%
controls:0.57%
cases:3.64%
controls:0.36%
—
—
cases:1.21%
controls:0.00%
—
—
cases:2.97%
controls:0.56%
cases:6.80%
controls:1.86%
20
28
474
4912
18
18
476
4922
—
6
0
488
4940
—
14
27
457
4785
27
77
370
4072
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
8.0e-01
1.7e+00
2.1e+00
—
2.3e+00
1.4e+00
1.2e+00
cases:4.86%
controls:2.25%
cases:3.24%
controls:0.63%
cases:1.01%
controls:0.12%
—
—
cases:1.83%
controls:0.18%
cases:2.76%
controls:0.73%
cases:7.05%
controls:2.22%
24
111
470
4829
16
31
478
4909
5
6
489
4934
—
9
9
484
4925
13
35
458
4777
28
92
369
4057
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
2.8e-01
5.9e-01
1.1e+00
3.8e+00
1.1e+00
7.7e-01
4.8e-01
cases:87.45%
controls:84.09%
cases:84.21%
controls:74.72%
cases:55.87%
controls:30.30%
cases:46.96%
controls:1.88%
cases:56.80%
controls:30.87%
cases:88.54%
controls:78.14%
cases:97.48%
controls:95.97%
432
4154
62
786
416
3691
78
1249
276
1497
218
3443
232
93
262
4847
280
1523
213
3411
417
3760
54
1052
387
3982
10
167
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.5e-01
9.2e-01
1.4e+00
—
2.6e+00
1.2e+00
7.3e-01
cases:13.36%
controls:8.20%
cases:9.72%
controls:4.11%
cases:2.23%
controls:0.57%
—
—
cases:4.06%
controls:0.32%
cases:10.62%
controls:3.49%
cases:19.40%
controls:10.36%
66
405
428
4535
48
203
446
4737
11
28
483
4912
—
20
16
473
4918
50
168
421
4644
77
430
320
3719
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
1.7e+00
2.6e+00
—
—
—
1.9e+00
1.1e+00
cases:2.23%
controls:0.43%
cases:2.63%
controls:0.20%
—
—
—
—
—
—
cases:2.55%
controls:0.39%
cases:4.28%
controls:1.47%
11
21
483
4919
13
10
481
4930
—
—
—
12
19
459
4793
17
61
380
4088
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
5.5e-01
9.3e-01
1.5e+00
—
2.5e+00
9.3e-01
8.2e-01
cases:18.42%
controls:11.50%
cases:13.36%
controls:5.71%
cases:3.24%
controls:0.73%
—
—
cases:5.27%
controls:0.47%
cases:12.95%
controls:5.53%
cases:32.24%
controls:17.31%
91
568
403
4372
66
282
428
4658
16
36
478
4904
—
26
23
467
4911
61
266
410
4546
128
718
269
3431
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.8e-01
4.4e-01
1.2e+00
3.7e+00
1.3e+00
5.9e-01
3.9e-01
cases:54.86%
controls:48.00%
cases:50.61%
controls:39.86%
cases:23.28%
controls:8.04%
cases:17.00%
controls:0.53%
cases:23.33%
controls:7.88%
cases:56.48%
controls:41.73%
cases:79.60%
controls:72.57%
271
2371
223
2569
250
1969
244
2971
115
397
379
4543
84
26
410
4914
115
389
378
4545
266
2008
205
2804
316
3011
81
1138
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.9e+00
1.8e+00
—
—
—
2.2e+00
1.4e+00
cases:4.05%
controls:0.65%
cases:2.23%
controls:0.38%
—
—
—
—
—
—
cases:2.12%
controls:0.25%
cases:3.78%
controls:0.96%
20
32
474
4908
11
19
483
4921
—
—
—
10
12
461
4800
15
40
382
4109
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
1.1e+00
1.5e+00
2.1e+00
—
—
1.5e+00
1.1e+00
cases:9.11%
controls:3.32%
cases:4.45%
controls:1.05%
cases:1.42%
controls:0.18%
—
—
—
—
cases:4.67%
controls:1.12%
cases:8.82%
controls:3.06%
45
164
449
4776
22
52
472
4888
7
9
487
4931
—
—
22
54
449
4758
35
127
362
4022
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-8.2e-03
2.2e-01
1.1e+00
3.9e+00
1.2e+00
4.9e-01
5.2e-01
cases:33.40%
controls:33.58%
cases:33.20%
controls:28.52%
cases:16.60%
controls:6.34%
cases:12.75%
controls:0.28%
cases:17.24%
controls:6.14%
cases:41.40%
controls:30.15%
cases:66.75%
controls:54.47%
165
1659
329
3281
164
1409
330
3531
82
313
412
4627
63
14
431
4926
85
303
408
4631
195
1451
276
3361
265
2260
132
1889
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
8.1e-01
1.4e+00
—
—
2.3e+00
1.4e+00
1.3e+00
cases:5.67%
controls:2.61%
cases:4.66%
controls:1.17%
—
—
—
—
cases:1.22%
controls:0.12%
cases:4.46%
controls:1.18%
cases:9.57%
controls:2.87%
28
129
466
4811
23
58
471
4882
—
—
6
6
487
4928
21
57
450
4755
38
119
359
4030
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.1e-01
3.2e-01
1.2e+00
3.8e+00
1.3e+00
5.3e-01
2.5e-01
cases:58.70%
controls:53.48%
cases:53.04%
controls:45.10%
cases:26.92%
controls:9.82%
cases:18.83%
controls:0.51%
cases:26.57%
controls:9.28%
cases:60.30%
controls:47.11%
cases:82.87%
controls:79.03%
290
2642
204
2298
262
2228
232
2712
133
485
361
4455
93
25
401
4915
131
458
362
4476
284
2267
187
2545
329
3279
68
870
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
7.6e-01
1.0e+00
1.9e+00
—
1.8e+00
9.2e-01
7.1e-01
cases:48.38%
controls:30.49%
cases:22.87%
controls:9.45%
cases:5.47%
controls:0.85%
—
—
cases:6.29%
controls:1.09%
cases:18.26%
controls:8.21%
cases:40.55%
controls:25.09%
239
1506
255
3434
113
467
381
4473
27
42
467
4898
—
31
54
462
4880
86
395
385
4417
161
1041
236
3108
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.2e-01
3.2e-01
1.2e+00
3.8e+00
1.3e+00
5.2e-01
2.5e-01
cases:58.70%
controls:53.38%
cases:53.04%
controls:45.16%
cases:26.92%
controls:9.82%
cases:18.83%
controls:0.51%
cases:26.57%
controls:9.30%
cases:60.08%
controls:47.15%
cases:82.87%
controls:79.10%
290
2637
204
2303
262
2231
232
2709
133
485
361
4455
93
25
401
4915
131
459
362
4475
283
2269
188
2543
329
3282
68
867
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
1.4e+00
1.6e+00
—
—
1.0e+50
2.0e+00
2.2e+00
cases:4.66%
controls:1.21%
cases:1.62%
controls:0.32%
—
—
—
—
cases:1.01%
controls:0.00%
cases:1.91%
controls:0.27%
cases:4.03%
controls:0.48%
23
60
471
4880
8
16
486
4924
—
—
5
0
488
4934
9
13
462
4799
16
20
381
4129
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.1e-01
3.2e-01
1.2e+00
3.8e+00
1.3e+00
5.3e-01
2.6e-01
cases:58.70%
controls:53.64%
cases:53.24%
controls:45.34%
cases:26.92%
controls:9.86%
cases:18.83%
controls:0.51%
cases:26.57%
controls:9.36%
cases:60.30%
controls:47.32%
cases:83.12%
controls:79.22%
290
2650
204
2290
263
2240
231
2700
133
487
361
4453
93
25
401
4915
131
462
362
4472
284
2277
187
2535
330
3287
67
862
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.2e-01
3.2e-01
1.2e+00
3.8e+00
1.3e+00
5.2e-01
2.5e-01
cases:58.91%
controls:53.56%
cases:53.24%
controls:45.36%
cases:26.92%
controls:9.90%
cases:18.83%
controls:0.51%
cases:26.57%
controls:9.36%
cases:60.08%
controls:47.22%
cases:83.12%
controls:79.27%
291
2646
203
2294
263
2241
231
2699
133
489
361
4451
93
25
401
4915
131
462
362
4472
283
2272
188
2540
330
3289
67
860
Endocrinology
46 [38004485]
46 [38004485]
9.3e-01
7.6e-01
1.4e+00
1.0e+50
2.0e+00
8.9e-01
9.3e-01
cases:10.12%
controls:4.27%
cases:5.87%
controls:2.83%
cases:2.83%
controls:0.69%
cases:1.01%
controls:0.00%
cases:3.45%
controls:0.49%
cases:6.58%
controls:2.81%
cases:13.10%
controls:5.62%
50
211
444
4729
29
140
465
4800
14
34
480
4906
5
0
489
4940
17
24
476
4910
31
135
440
4677
52
233
345
3916
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
2.0e-01
1.1e+00
1.9e+00
1.0e+50
2.0e+00
1.1e+00
7.8e-01
cases:6.07%
controls:5.04%
cases:10.12%
controls:3.52%
cases:3.85%
controls:0.59%
cases:5.06%
controls:0.00%
cases:3.25%
controls:0.45%
cases:11.46%
controls:4.26%
cases:30.23%
controls:16.58%
30
249
464
4691
50
174
444
4766
19
29
475
4911
25
0
469
4940
16
22
477
4912
54
205
417
4607
120
688
277
3461
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
4.5e-01
9.9e-01
1.6e+00
1.0e+50
1.9e+00
9.4e-01
1.0e+00
cases:23.28%
controls:16.26%
cases:20.65%
controls:8.81%
cases:6.28%
controls:1.28%
cases:7.49%
controls:0.00%
cases:6.29%
controls:1.03%
cases:20.17%
controls:9.00%
cases:48.11%
controls:25.23%
115
803
379
4137
102
435
392
4505
31
63
463
4877
37
0
457
4940
31
51
462
4883
95
433
376
4379
191
1047
206
3102
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
1.8e+00
2.3e+00
—
1.0e+50
—
1.4e+00
1.3e+00
cases:4.05%
controls:0.67%
cases:4.45%
controls:0.47%
—
—
cases:1.21%
controls:0.00%
—
—
cases:2.76%
controls:0.69%
cases:6.30%
controls:1.81%
20
33
474
4907
22
23
472
4917
—
6
0
488
4940
—
13
33
458
4779
25
75
372
4074
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.1e-01
3.1e-01
1.2e+00
3.8e+00
1.3e+00
5.3e-01
2.6e-01
cases:58.70%
controls:53.52%
cases:53.04%
controls:45.22%
cases:26.92%
controls:9.82%
cases:18.83%
controls:0.51%
cases:26.57%
controls:9.32%
cases:60.30%
controls:47.17%
cases:83.12%
controls:79.18%
290
2644
204
2296
262
2234
232
2706
133
485
361
4455
93
25
401
4915
131
460
362
4474
284
2270
187
2542
330
3285
67
864
Type 2 diabetes mellitus, with peripheral circulatory complications
E11.5 [45557114]
E11.5 [45557114]
2.2e+00
2.1e+00
—
—
—
2.2e+00
2.5e+00
cases:2.23%
controls:0.26%
cases:1.01%
controls:0.12%
—
—
—
—
—
—
cases:1.49%
controls:0.17%
cases:2.77%
controls:0.24%
11
13
483
4927
5
6
489
4934
—
—
—
7
8
464
4804
11
10
386
4139
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.1e-01
3.1e-01
1.2e+00
3.8e+00
1.3e+00
5.3e-01
2.6e-01
cases:58.70%
controls:53.50%
cases:53.04%
controls:45.24%
cases:26.92%
controls:9.84%
cases:18.83%
controls:0.51%
cases:26.57%
controls:9.34%
cases:60.30%
controls:47.24%
cases:83.12%
controls:79.20%
290
2643
204
2297
262
2235
232
2705
133
486
361
4454
93
25
401
4915
131
461
362
4473
284
2273
187
2539
330
3286
67
863
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
5.5e-01
9.3e-01
1.5e+00
—
1.8e+00
1.0e+00
9.6e-01
cases:19.43%
controls:12.19%
cases:18.42%
controls:8.20%
cases:5.26%
controls:1.19%
—
—
cases:7.10%
controls:1.24%
cases:19.32%
controls:7.81%
cases:41.56%
controls:21.33%
96
602
398
4338
91
405
403
4535
26
59
468
4881
—
35
61
458
4873
91
376
380
4436
165
885
232
3264
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.1e-01
3.1e-01
1.2e+00
3.8e+00
1.3e+00
5.2e-01
2.6e-01
cases:58.70%
controls:53.54%
cases:53.04%
controls:45.26%
cases:26.92%
controls:9.86%
cases:18.83%
controls:0.51%
cases:26.57%
controls:9.34%
cases:60.08%
controls:47.17%
cases:83.12%
controls:79.15%
290
2645
204
2295
262
2236
232
2704
133
487
361
4453
93
25
401
4915
131
461
362
4473
283
2270
188
2542
330
3284
67
865
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
7.4e-01
1.2e+00
1.7e+00
—
1.6e+00
8.4e-01
7.2e-01
cases:17.21%
controls:9.05%
cases:12.55%
controls:4.11%
cases:3.44%
controls:0.67%
—
—
cases:3.65%
controls:0.79%
cases:11.25%
controls:5.20%
cases:26.20%
controls:14.68%
85
447
409
4493
62
203
432
4737
17
33
477
4907
—
18
39
475
4895
53
250
418
4562
104
609
293
3540
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
8.8e-01
8.7e-01
1.6e+00
—
3.1e+00
1.7e+00
1.0e+00
cases:7.49%
controls:3.26%
cases:3.44%
controls:1.48%
cases:1.42%
controls:0.28%
—
—
cases:3.04%
controls:0.14%
cases:6.79%
controls:1.33%
cases:9.82%
controls:3.76%
37
161
457
4779
17
73
477
4867
7
14
487
4926
—
15
7
478
4927
32
64
439
4748
39
156
358
3993
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
1.6e+00
1.8e+00
-1.0e+50
—
—
1.6e+00
1.5e+00
cases:3.44%
controls:0.73%
cases:2.63%
controls:0.45%
cases:0.00%
controls:0.14%
—
—
—
—
cases:2.34%
controls:0.46%
cases:4.79%
controls:1.06%
17
36
477
4904
13
22
481
4918
0
7
494
4933
—
—
11
22
460
4790
19
44
378
4105
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.6e+00
2.2e+00
—
1.0e+50
—
1.4e+00
1.3e+00
cases:5.67%
controls:1.21%
cases:5.06%
controls:0.57%
—
—
cases:1.82%
controls:0.00%
—
—
cases:3.40%
controls:0.83%
cases:10.08%
controls:2.96%
28
60
466
4880
25
28
469
4912
—
9
0
485
4940
—
16
40
455
4772
40
123
357
4026
Treatment of a patient needing special arrangements
WYA30 [2001310874]
WYA30 [2001310874]
1.3e+00
1.7e+00
—
—
—
1.6e+00
1.9e+00
cases:4.05%
controls:1.13%
cases:2.02%
controls:0.38%
—
—
—
—
—
—
cases:2.34%
controls:0.50%
cases:6.80%
controls:1.08%
20
56
474
4884
10
19
484
4921
—
—
—
11
24
460
4788
27
45
370
4104
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
1.7e+00
2.2e+00
—
1.0e+50
—
1.4e+00
1.2e+00
cases:3.64%
controls:0.69%
cases:4.05%
controls:0.49%
—
—
cases:1.21%
controls:0.00%
—
—
cases:2.76%
controls:0.71%
cases:8.06%
controls:2.58%
18
34
476
4906
20
24
474
4916
—
6
0
488
4940
—
13
34
458
4778
32
107
365
4042
Allergy, unspecified
T78.4 [45580373]
T78.4 [45580373]
1.6e+00
—
—
1.0e+50
—
2.5e+00
2.3e+00
cases:2.83%
controls:0.59%
—
—
—
—
cases:10.53%
controls:0.00%
—
—
cases:2.34%
controls:0.19%
cases:3.78%
controls:0.41%
14
29
480
4911
—
—
52
0
442
4940
—
11
9
460
4803
15
17
382
4132
No procedures
SPAT1301 [2001700402]
SPAT1301 [2001700402]
7.7e-01
1.1e+00
1.3e+00
—
1.5e+00
8.7e-01
8.8e-01
cases:18.22%
controls:9.35%
cases:9.31%
controls:3.44%
cases:2.23%
controls:0.63%
—
—
cases:3.45%
controls:0.77%
cases:7.64%
controls:3.37%
cases:15.11%
controls:6.87%
90
462
404
4478
46
170
448
4770
11
31
483
4909
—
17
38
476
4896
36
162
435
4650
60
285
337
3864
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
8.9e-01
8.6e-01
1.8e+00
—
2.6e+00
1.6e+00
1.2e+00
cases:5.06%
controls:2.15%
cases:2.63%
controls:1.13%
cases:1.21%
controls:0.20%
—
—
cases:2.43%
controls:0.18%
cases:4.67%
controls:0.96%
cases:13.10%
controls:4.22%
25
106
469
4834
13
56
481
4884
6
10
488
4930
—
12
9
481
4925
22
46
449
4766
52
175
345
3974
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
7.5e-01
9.8e-01
1.6e+00
—
2.2e+00
1.2e+00
1.3e+00
cases:7.09%
controls:3.46%
cases:3.44%
controls:1.32%
cases:1.01%
controls:0.20%
—
—
cases:1.22%
controls:0.14%
cases:3.82%
controls:1.21%
cases:11.34%
controls:3.45%
35
171
459
4769
17
65
477
4875
5
10
489
4930
—
6
7
487
4927
18
58
453
4754
45
143
352
4006
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
E11.7 [45561950]
1.6e+00
1.7e+00
—
—
—
1.4e+00
1.6e+00
cases:4.05%
controls:0.81%
cases:2.63%
controls:0.51%
—
—
—
—
—
—
cases:2.34%
controls:0.58%
cases:5.29%
controls:1.08%
20
40
474
4900
13
25
481
4915
—
—
—
11
28
460
4784
21
45
376
4104
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
8.6e-01
1.0e+00
—
—
2.1e+00
1.2e+00
1.1e+00
cases:6.07%
controls:2.67%
cases:4.45%
controls:1.62%
—
—
—
—
cases:2.03%
controls:0.24%
cases:5.31%
controls:1.72%
cases:15.87%
controls:5.95%
30
132
464
4808
22
80
472
4860
—
—
10
12
483
4922
25
83
446
4729
63
247
334
3902
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
6.0e-01
1.1e+00
1.5e+00
1.0e+50
2.1e+00
1.2e+00
1.3e+00
cases:11.54%
controls:6.66%
cases:7.29%
controls:2.61%
cases:1.42%
controls:0.32%
cases:1.42%
controls:0.00%
cases:2.84%
controls:0.36%
cases:7.01%
controls:2.24%
cases:16.62%
controls:5.11%
57
329
437
4611
36
129
458
4811
7
16
487
4924
7
0
487
4940
14
18
479
4916
33
108
438
4704
66
212
331
3937
Recurrent depressive disorder, unspecified
F33.9 [45581458]
F33.9 [45581458]
1.3e+00
2.5e+00
—
—
—
2.2e+00
1.6e+00
cases:1.82%
controls:0.51%
cases:1.62%
controls:0.14%
—
—
—
—
—
—
cases:1.49%
controls:0.17%
cases:3.27%
controls:0.70%
9
25
485
4915
8
7
486
4933
—
—
—
7
8
464
4804
13
29
384
4120
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
1.1e+00
1.4e+00
—
1.0e+50
—
2.4e+00
1.3e+00
cases:8.50%
controls:3.06%
cases:4.25%
controls:1.05%
—
—
cases:1.82%
controls:0.00%
—
—
cases:6.37%
controls:0.60%
cases:9.57%
controls:2.84%
42
151
452
4789
21
52
473
4888
—
9
0
485
4940
—
30
29
441
4783
38
118
359
4031
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
8.3e-01
1.0e+00
1.2e+00
—
2.0e+00
1.2e+00
1.1e+00
cases:5.67%
controls:2.55%
cases:4.25%
controls:1.56%
cases:1.01%
controls:0.30%
—
—
cases:1.83%
controls:0.24%
cases:5.10%
controls:1.56%
cases:14.61%
controls:5.54%
28
126
466
4814
21
77
473
4863
5
15
489
4925
—
9
12
484
4922
24
75
447
4737
58
230
339
3919
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
6.4e-01
9.4e-01
1.3e+00
1.1e+00
1.4e+00
9.2e-01
9.3e-01
cases:13.56%
controls:7.61%
cases:10.53%
controls:4.41%
cases:4.86%
controls:1.44%
cases:1.21%
controls:0.43%
cases:5.88%
controls:1.46%
cases:11.25%
controls:4.80%
cases:24.69%
controls:11.45%
67
376
427
4564
52
218
442
4722
24
71
470
4869
6
21
488
4919
29
72
464
4862
53
231
418
4581
98
475
299
3674
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
1.1e+00
1.3e+00
1.5e+00
—
1.4e+00
1.3e+00
9.6e-01
cases:8.70%
controls:3.14%
cases:6.88%
controls:1.96%
cases:2.02%
controls:0.47%
—
—
cases:1.42%
controls:0.36%
cases:5.73%
controls:1.68%
cases:12.34%
controls:5.11%
43
155
451
4785
34
97
460
4843
10
23
484
4917
—
7
18
486
4916
27
81
444
4731
49
212
348
3937
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
4.9e-01
7.2e-01
1.5e+00
—
1.5e+00
9.7e-01
9.1e-01
cases:17.21%
controls:11.34%
cases:13.77%
controls:7.21%
cases:5.47%
controls:1.30%
—
—
cases:5.68%
controls:1.32%
cases:16.35%
controls:6.92%
cases:33.75%
controls:16.99%
85
560
409
4380
68
356
426
4584
27
64
467
4876
—
28
65
465
4869
77
333
394
4479
134
705
263
3444
General Practice Dentistry
1223G0001X [38003675]
1223G0001X [38003675]
1.3e+00
1.8e+00
—
1.0e+50
—
2.9e+00
1.3e+00
cases:2.83%
controls:0.79%
cases:2.02%
controls:0.32%
—
—
cases:1.42%
controls:0.00%
—
—
cases:2.97%
controls:0.17%
cases:2.52%
controls:0.67%
14
39
480
4901
10
16
484
4924
—
7
0
487
4940
—
14
8
457
4804
10
28
387
4121
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
9.4e-01
1.0e+00
1.6e+00
—
1.6e+00
1.3e+00
1.2e+00
cases:5.67%
controls:2.29%
cases:3.64%
controls:1.32%
cases:2.23%
controls:0.47%
—
—
cases:1.42%
controls:0.28%
cases:4.88%
controls:1.35%
cases:8.82%
controls:2.94%
28
113
466
4827
18
65
476
4875
11
23
483
4917
—
7
14
486
4920
23
65
448
4747
35
122
362
4027
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
8.9e-01
8.6e-01
1.4e+00
—
2.1e+00
1.1e+00
1.1e+00
cases:6.88%
controls:2.94%
cases:4.45%
controls:1.94%
cases:1.21%
controls:0.30%
—
—
cases:2.03%
controls:0.26%
cases:5.52%
controls:1.95%
cases:16.88%
controls:6.31%
34
145
460
4795
22
96
472
4844
6
15
488
4925
—
10
13
483
4921
26
94
445
4718
67
262
330
3887
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
6.4e-01
1.3e+00
2.3e+00
1.0e+50
—
1.3e+00
9.7e-01
cases:4.05%
controls:2.17%
cases:3.85%
controls:1.11%
cases:1.42%
controls:0.14%
cases:1.21%
controls:0.00%
—
—
cases:4.03%
controls:1.08%
cases:12.09%
controls:4.97%
20
107
474
4833
19
55
475
4885
7
7
487
4933
6
0
488
4940
—
19
52
452
4760
48
206
349
3943
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.2e-01
9.3e-01
1.2e+00
—
1.3e+00
9.8e-01
9.4e-01
cases:21.05%
controls:13.64%
cases:19.23%
controls:8.60%
cases:5.67%
controls:1.80%
—
—
cases:6.49%
controls:1.86%
cases:18.26%
controls:7.71%
cases:41.31%
controls:21.52%
104
674
390
4266
95
425
399
4515
28
89
466
4851
—
32
92
461
4842
86
371
385
4441
164
893
233
3256
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
5.4e-01
7.2e-01
1.5e+00
2.1e+00
1.7e+00
7.5e-01
6.8e-01
cases:12.75%
controls:7.85%
cases:10.93%
controls:5.65%
cases:4.66%
controls:1.09%
cases:1.01%
controls:0.12%
cases:5.68%
controls:1.13%
cases:12.53%
controls:6.36%
cases:25.44%
controls:14.68%
63
388
431
4552
54
279
440
4661
23
54
471
4886
5
6
489
4934
28
56
465
4878
59
306
412
4506
101
609
296
3540
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
2.1e+00
2.2e+00
—
—
—
1.5e+00
5.7e-01
cases:3.64%
controls:0.47%
cases:2.23%
controls:0.24%
—
—
—
—
—
—
cases:1.91%
controls:0.44%
cases:3.78%
controls:2.17%
18
23
476
4917
11
12
483
4928
—
—
—
9
21
462
4791
15
90
382
4059
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
5.1e-01
7.0e-01
1.3e+00
—
1.6e+00
9.3e-01
7.9e-01
cases:14.78%
controls:9.43%
cases:10.12%
controls:5.28%
cases:2.43%
controls:0.69%
—
—
cases:3.04%
controls:0.63%
cases:10.19%
controls:4.28%
cases:25.44%
controls:13.42%
73
466
421
4474
50
261
444
4679
12
34
482
4906
—
15
31
478
4903
48
206
423
4606
101
557
296
3592
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
6.4e-01
1.2e+00
1.4e+00
1.0e+50
1.8e+00
1.1e+00
1.1e+00
cases:12.35%
controls:6.92%
cases:10.32%
controls:3.46%
cases:1.62%
controls:0.40%
cases:2.02%
controls:0.00%
cases:2.64%
controls:0.43%
cases:9.98%
controls:3.72%
cases:27.96%
controls:11.47%
61
342
433
4598
51
171
443
4769
8
20
486
4920
10
0
484
4940
13
21
480
4913
47
179
424
4633
111
476
286
3673
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
1.9e+00
1.9e+00
—
—
—
1.5e+00
2.0e+00
cases:2.02%
controls:0.30%
cases:1.82%
controls:0.28%
—
—
—
—
—
—
cases:1.06%
controls:0.25%
cases:2.77%
controls:0.39%
10
15
484
4925
9
14
485
4926
—
—
—
5
12
466
4800
11
16
386
4133
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.1e-01
8.5e-01
1.6e+00
—
1.7e+00
9.5e-01
7.3e-01
cases:15.99%
controls:11.26%
cases:15.99%
controls:7.51%
cases:4.66%
controls:1.01%
—
—
cases:5.68%
controls:1.13%
cases:16.77%
controls:7.21%
cases:32.75%
controls:19.02%
79
556
415
4384
79
371
415
4569
23
50
471
4890
—
28
56
465
4878
79
347
392
4465
130
789
267
3360
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
1.2e+00
1.3e+00
—
—
—
1.7e+00
1.4e+00
cases:11.74%
controls:3.72%
cases:3.85%
controls:1.07%
—
—
—
—
—
—
cases:4.88%
controls:0.89%
cases:11.59%
controls:3.04%
58
184
436
4756
19
53
475
4887
—
—
—
23
43
448
4769
46
126
351
4023
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
100906-7 [1761482]
2.2e+00
2.2e+00
—
—
—
1.4e+00
1.4e+00
cases:4.86%
controls:0.59%
cases:2.83%
controls:0.32%
—
—
—
—
—
—
cases:1.91%
controls:0.48%
cases:4.53%
controls:1.21%
24
29
470
4911
14
16
480
4924
—
—
—
9
23
462
4789
18
50
379
4099
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
4.9e-01
6.6e-01
1.8e+00
—
2.4e+00
9.2e-01
5.7e-01
cases:8.10%
controls:5.14%
cases:5.06%
controls:2.67%
cases:2.23%
controls:0.38%
—
—
cases:2.43%
controls:0.22%
cases:5.94%
controls:2.45%
cases:14.11%
controls:8.53%
40
254
454
4686
25
132
469
4808
11
19
483
4921
—
12
11
481
4923
28
118
443
4694
56
354
341
3795
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
1.9e-02
9.8e-02
9.5e-01
3.6e+00
1.1e+00
1.7e-01
-2.6e-01
cases:42.11%
controls:41.64%
cases:34.41%
controls:32.23%
cases:16.19%
controls:6.98%
cases:10.12%
controls:0.30%
cases:16.23%
controls:6.12%
cases:36.73%
controls:32.98%
cases:53.65%
controls:59.92%
208
2057
286
2883
170
1592
324
3348
80
345
414
4595
50
15
444
4925
80
302
413
4632
173
1587
298
3225
213
2486
184
1663
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
5.4e-01
1.2e+00
1.6e+00
1.0e+50
1.5e+00
1.5e+00
9.8e-01
cases:12.15%
controls:7.45%
cases:8.70%
controls:2.89%
cases:1.42%
controls:0.30%
cases:5.47%
controls:0.00%
cases:2.23%
controls:0.53%
cases:10.62%
controls:2.64%
cases:19.40%
controls:8.32%
60
368
434
4572
43
143
451
4797
7
15
487
4925
27
0
467
4940
11
26
482
4908
50
127
421
4685
77
345
320
3804
lactulose; oral
A06AD11 [21600571]
A06AD11 [21600571]
1.0e+00
1.4e+00
1.2e+00
—
—
1.5e+00
1.8e+00
cases:4.66%
controls:1.72%
cases:3.64%
controls:0.95%
cases:1.01%
controls:0.30%
—
—
—
—
cases:3.82%
controls:0.91%
cases:8.82%
controls:1.64%
23
85
471
4855
18
47
476
4893
5
15
489
4925
—
—
18
44
453
4768
35
68
362
4081
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
SPAT1149 [2001700250]
1.1e+00
1.5e+00
—
—
—
1.8e+00
1.2e+00
cases:7.29%
controls:2.49%
cases:2.83%
controls:0.67%
—
—
—
—
—
—
cases:3.82%
controls:0.62%
cases:5.54%
controls:1.78%
36
123
458
4817
14
33
480
4907
—
—
—
18
30
453
4782
22
74
375
4075
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
1.7e+00
1.6e+00
—
—
—
2.3e+00
1.1e+00
cases:4.05%
controls:0.79%
cases:1.62%
controls:0.32%
—
—
—
—
—
—
cases:2.76%
controls:0.29%
cases:3.02%
controls:1.01%
20
39
474
4901
8
16
486
4924
—
—
—
13
14
458
4798
12
42
385
4107
Other chronic renal failure
N18.8 [45534123]
N18.8 [45534123]
1.7e+00
2.3e+00
—
—
—
1.2e+00
1.5e+00
cases:2.02%
controls:0.36%
cases:1.62%
controls:0.16%
—
—
—
—
—
—
cases:1.06%
controls:0.31%
cases:2.27%
controls:0.51%
10
18
484
4922
8
8
486
4932
—
—
—
5
15
466
4797
9
21
388
4128
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
1.1e+00
1.8e+00
—
—
—
1.7e+00
8.6e-01
cases:3.85%
controls:1.30%
cases:3.64%
controls:0.61%
—
—
—
—
—
—
cases:3.18%
controls:0.58%
cases:6.05%
controls:2.65%
19
64
475
4876
18
30
476
4910
—
—
—
15
28
456
4784
24
110
373
4039
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
2.4e-01
3.3e-01
8.5e-01
2.9e+00
1.0e+00
4.1e-01
3.4e-01
cases:51.42%
controls:45.55%
cases:42.31%
controls:34.49%
cases:13.77%
controls:6.40%
cases:4.86%
controls:0.28%
cases:14.60%
controls:5.82%
cases:46.50%
controls:36.55%
cases:77.08%
controls:70.50%
254
2250
240
2690
209
1704
285
3236
68
316
426
4624
24
14
470
4926
72
287
421
4647
219
1759
252
3053
306
2925
91
1224
prazosin; oral
C02CA01 [21600411]
C02CA01 [21600411]
2.1e+00
1.8e+00
—
—
—
2.0e+00
1.4e+00
cases:2.02%
controls:0.26%
cases:1.01%
controls:0.16%
—
—
—
—
—
—
cases:1.70%
controls:0.23%
cases:2.52%
controls:0.63%
10
13
484
4927
5
8
489
4932
—
—
—
8
11
463
4801
10
26
387
4123
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
7.6e-01
9.3e-01
5.4e-01
—
2.0e+00
9.4e-01
8.7e-01
cases:22.67%
controls:12.09%
cases:12.55%
controls:5.34%
cases:1.62%
controls:0.95%
—
—
cases:5.88%
controls:0.85%
cases:12.10%
controls:5.11%
cases:25.44%
controls:12.51%
112
597
382
4343
62
264
432
4676
8
47
486
4893
—
29
42
464
4892
57
246
414
4566
101
519
296
3630
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
7.6e-01
9.0e-01
5.4e-01
—
2.0e+00
9.5e-01
8.8e-01
cases:22.67%
controls:12.04%
cases:12.15%
controls:5.32%
cases:1.62%
controls:0.95%
—
—
cases:5.88%
controls:0.85%
cases:12.10%
controls:5.07%
cases:25.44%
controls:12.41%
112
595
382
4345
60
263
434
4677
8
47
486
4893
—
29
42
464
4892
57
244
414
4568
101
515
296
3634
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
6.8e-01
1.1e+00
1.3e+00
—
1.9e+00
8.9e-01
8.9e-01
cases:12.55%
controls:6.76%
cases:10.32%
controls:3.60%
cases:1.62%
controls:0.47%
—
—
cases:3.45%
controls:0.55%
cases:8.70%
controls:3.76%
cases:24.94%
controls:11.98%
62
334
432
4606
51
178
443
4762
8
23
486
4917
—
17
27
476
4907
41
181
430
4631
99
497
298
3652
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
6.6e-01
1.3e+00
1.4e+00
1.0e+50
1.9e+00
1.1e+00
5.8e-01
cases:9.31%
controls:5.06%
cases:7.29%
controls:2.19%
cases:1.01%
controls:0.24%
cases:1.21%
controls:0.00%
cases:2.64%
controls:0.41%
cases:7.86%
controls:2.87%
cases:20.65%
controls:12.68%
46
250
448
4690
36
108
458
4832
5
12
489
4928
6
0
488
4940
13
20
480
4914
37
138
434
4674
82
526
315
3623
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
9.1e-02
2.3e-01
1.0e+00
3.4e+00
9.8e-01
3.2e-01
4.1e-02
cases:62.75%
controls:60.61%
cases:62.35%
controls:56.72%
cases:37.65%
controls:17.75%
cases:24.29%
controls:1.03%
cases:36.51%
controls:17.69%
cases:67.94%
controls:60.54%
cases:86.65%
controls:86.17%
310
2994
184
1946
308
2802
186
2138
186
877
308
4063
120
51
374
4889
180
873
313
4061
320
2913
151
1899
344
3575
53
574
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
1.2e+00
1.8e+00
—
—
—
1.4e+00
1.1e+00
cases:3.24%
controls:0.99%
cases:3.04%
controls:0.53%
—
—
—
—
—
—
cases:2.55%
controls:0.67%
cases:5.79%
controls:2.05%
16
49
478
4891
15
26
479
4914
—
—
—
12
32
459
4780
23
85
374
4064
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
SPAT1144 [2001700245]
1.3e+00
—
—
—
—
2.9e+00
1.3e+00
cases:4.05%
controls:1.17%
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.15%
cases:3.02%
controls:0.87%
20
58
474
4882
—
—
—
—
12
7
459
4805
12
36
385
4113
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.6e+00
—
—
—
—
—
2.8e+00
cases:2.23%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:2.27%
controls:0.14%
11
8
483
4932
—
—
—
—
—
9
6
388
4143
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.5e-01
7.6e-01
1.5e+00
—
1.4e+00
9.2e-01
8.1e-01
cases:10.32%
controls:8.26%
cases:9.31%
controls:4.57%
cases:2.43%
controls:0.55%
—
—
cases:2.43%
controls:0.61%
cases:10.19%
controls:4.32%
cases:26.45%
controls:13.74%
51
408
443
4532
46
226
448
4714
12
27
482
4913
—
12
30
481
4904
48
208
423
4604
105
570
292
3579
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
8.6e-01
9.1e-01
8.2e-01
1.9e+00
9.1e-01
8.2e-01
1.7e+00
cases:98.58%
controls:96.72%
cases:94.94%
controls:88.32%
cases:69.84%
controls:50.55%
cases:16.80%
controls:2.79%
cases:72.01%
controls:50.81%
cases:94.90%
controls:89.11%
cases:99.50%
controls:97.37%
487
4778
7
162
469
4363
25
577
345
2497
149
2443
83
138
411
4802
355
2507
138
2427
447
4288
24
524
395
4040
2
109
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
2.7e+00
—
—
—
—
—
2.7e+00
cases:2.43%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:4.03%
controls:0.29%
12
8
482
4932
—
—
—
—
—
16
12
381
4137
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
1.2e+00
1.6e+00
—
—
—
1.5e+00
1.1e+00
cases:2.63%
controls:0.83%
cases:2.43%
controls:0.51%
—
—
—
—
—
—
cases:2.34%
controls:0.52%
cases:4.03%
controls:1.37%
13
41
481
4899
12
25
482
4915
—
—
—
11
25
460
4787
16
57
381
4092
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
1.2e+00
1.7e+00
—
—
—
1.4e+00
1.0e+00
cases:3.44%
controls:1.01%
cases:3.04%
controls:0.55%
—
—
—
—
—
—
cases:2.76%
controls:0.71%
cases:6.30%
controls:2.39%
17
50
477
4890
15
27
479
4913
—
—
—
13
34
458
4778
25
99
372
4050
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
6.7e-01
9.0e-01
—
—
2.0e+00
1.0e+00
7.6e-01
cases:14.17%
controls:7.79%
cases:5.26%
controls:2.21%
—
—
—
—
cases:1.22%
controls:0.16%
cases:5.52%
controls:2.08%
cases:9.82%
controls:4.84%
70
385
424
4555
26
109
468
4831
—
—
6
8
487
4926
26
100
445
4712
39
201
358
3948
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
6.2e-01
8.6e-01
1.2e+00
—
1.2e+00
8.0e-01
6.9e-01
cases:10.53%
controls:5.95%
cases:7.09%
controls:3.12%
cases:2.63%
controls:0.83%
—
—
cases:2.64%
controls:0.79%
cases:6.79%
controls:3.18%
cases:12.09%
controls:6.46%
52
294
442
4646
35
154
459
4786
13
41
481
4899
—
13
39
480
4895
32
153
439
4659
48
268
349
3881
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
6.3e-01
8.1e-01
1.4e+00
—
1.3e+00
5.8e-01
7.1e-01
cases:34.82%
controls:22.19%
cases:23.89%
controls:12.29%
cases:5.87%
controls:1.56%
—
—
cases:6.90%
controls:2.07%
cases:20.17%
controls:12.34%
cases:48.36%
controls:31.60%
172
1096
322
3844
118
607
376
4333
29
77
465
4863
—
34
102
459
4832
95
594
376
4218
192
1311
205
2838
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
8.6e-01
9.2e-01
—
—
2.2e+00
1.3e+00
9.8e-01
cases:7.69%
controls:3.40%
cases:3.04%
controls:1.23%
—
—
—
—
cases:1.22%
controls:0.14%
cases:4.03%
controls:1.10%
cases:10.83%
controls:4.36%
38
168
456
4772
15
61
479
4879
—
—
6
7
487
4927
19
53
452
4759
43
181
354
3968
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
1.2e+00
1.7e+00
—
—
—
1.4e+00
9.8e-01
cases:3.44%
controls:1.01%
cases:3.04%
controls:0.57%
—
—
—
—
—
—
cases:2.76%
controls:0.71%
cases:6.30%
controls:2.46%
17
50
477
4890
15
28
479
4912
—
—
—
13
34
458
4778
25
102
372
4047
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
1.5e+00
2.1e+00
2.3e+00
—
—
1.7e+00
8.5e-01
cases:3.64%
controls:0.81%
cases:2.83%
controls:0.36%
cases:1.01%
controls:0.10%
—
—
—
—
cases:2.55%
controls:0.48%
cases:2.77%
controls:1.21%
18
40
476
4900
14
18
480
4922
5
5
489
4935
—
—
12
23
459
4789
11
50
386
4099
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
1.2e+00
—
—
—
—
2.2e+00
1.8e+00
cases:2.83%
controls:0.85%
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.17%
cases:3.27%
controls:0.53%
14
42
480
4898
—
—
—
—
7
8
464
4804
13
22
384
4127
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.7e-01
7.4e-01
1.5e+00
2.1e+00
1.6e+00
6.9e-01
7.3e-01
cases:17.81%
controls:13.02%
cases:15.99%
controls:8.32%
cases:6.48%
controls:1.50%
cases:1.01%
controls:0.12%
cases:6.90%
controls:1.50%
cases:15.50%
controls:8.46%
cases:36.27%
controls:21.48%
88
643
406
4297
79
411
415
4529
32
74
462
4866
5
6
489
4934
34
74
459
4860
73
407
398
4405
144
891
253
3258
Headache
R51.80 [2000503603]
R51.80 [2000503603]
8.0e-01
1.5e+00
—
—
—
1.6e+00
1.3e+00
cases:4.86%
controls:2.25%
cases:3.24%
controls:0.71%
—
—
—
—
—
—
cases:2.55%
controls:0.52%
cases:9.07%
controls:2.65%
24
111
470
4829
16
35
478
4905
—
—
—
12
25
459
4787
36
110
361
4039
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.7e-01
7.4e-01
1.5e+00
2.1e+00
1.6e+00
7.0e-01
7.0e-01
cases:17.81%
controls:13.04%
cases:15.99%
controls:8.30%
cases:6.48%
controls:1.50%
cases:1.01%
controls:0.12%
cases:6.90%
controls:1.50%
cases:15.71%
controls:8.48%
cases:35.77%
controls:21.64%
88
644
406
4296
79
410
415
4530
32
74
462
4866
5
6
489
4934
34
74
459
4860
74
408
397
4404
142
898
255
3251
Calcium.ionized [Moles/volume] in Venous blood
41645-3 [3033705]
41645-3 [3033705]
2.6e+00
2.7e+00
—
—
—
1.5e+00
1.0e+00
cases:2.63%
controls:0.20%
cases:1.42%
controls:0.10%
—
—
—
—
—
—
cases:1.06%
controls:0.23%
cases:1.26%
controls:0.46%
13
10
481
4930
7
5
487
4935
—
—
—
5
11
466
4801
5
19
392
4130
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.7e-01
7.4e-01
1.5e+00
2.1e+00
1.6e+00
6.9e-01
7.1e-01
cases:17.81%
controls:12.98%
cases:15.99%
controls:8.32%
cases:6.28%
controls:1.48%
cases:1.01%
controls:0.12%
cases:6.90%
controls:1.50%
cases:15.50%
controls:8.44%
cases:36.02%
controls:21.60%
88
641
406
4299
79
411
415
4529
31
73
463
4867
5
6
489
4934
34
74
459
4860
73
406
398
4406
143
896
254
3253
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
7.8e-01
6.1e-01
1.4e+00
—
2.1e+00
1.5e+00
7.9e-01
cases:15.59%
controls:7.77%
cases:6.07%
controls:3.38%
cases:2.02%
controls:0.53%
—
—
cases:3.65%
controls:0.45%
cases:13.38%
controls:3.39%
cases:17.13%
controls:8.58%
77
384
417
4556
30
167
464
4773
10
26
484
4914
—
18
22
475
4912
63
163
408
4649
68
356
329
3793
Potassium [Moles/volume] in Venous blood
39789-3 [3041354]
39789-3 [3041354]
2.5e+00
2.7e+00
—
—
—
1.7e+00
1.2e+00
cases:2.63%
controls:0.22%
cases:1.42%
controls:0.10%
—
—
—
—
—
—
cases:1.27%
controls:0.23%
cases:1.51%
controls:0.46%
13
11
481
4929
7
5
487
4935
—
—
—
6
11
465
4801
6
19
391
4130
Chloride [Moles/volume] in Venous blood
41649-5 [3035285]
41649-5 [3035285]
2.5e+00
2.7e+00
—
—
—
1.7e+00
1.2e+00
cases:2.63%
controls:0.22%
cases:1.42%
controls:0.10%
—
—
—
—
—
—
cases:1.27%
controls:0.23%
cases:1.51%
controls:0.46%
13
11
481
4929
7
5
487
4935
—
—
—
6
11
465
4801
6
19
391
4130
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
8.2e-01
1.1e+00
1.3e+00
1.0e+50
1.5e+00
8.9e-01
8.3e-01
cases:14.37%
controls:6.88%
cases:10.73%
controls:3.74%
cases:1.82%
controls:0.53%
cases:1.01%
controls:0.00%
cases:2.43%
controls:0.57%
cases:9.13%
controls:3.97%
cases:24.18%
controls:12.22%
71
340
423
4600
53
185
441
4755
9
26
485
4914
5
0
489
4940
12
28
481
4906
43
191
428
4621
96
507
301
3642
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
5.3e-01
1.1e+00
1.7e+00
—
2.2e+00
9.8e-01
8.4e-01
cases:4.25%
controls:2.55%
cases:4.45%
controls:1.54%
cases:1.01%
controls:0.18%
—
—
cases:1.83%
controls:0.20%
cases:4.25%
controls:1.64%
cases:14.11%
controls:6.60%
21
126
473
4814
22
76
472
4864
5
9
489
4931
—
9
10
484
4924
20
79
451
4733
56
274
341
3875
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
8.6e-01
9.1e-01
1.0e+00
—
1.7e+00
1.3e+00
1.2e+00
cases:6.48%
controls:2.85%
cases:3.44%
controls:1.42%
cases:1.01%
controls:0.36%
—
—
cases:2.23%
controls:0.41%
cases:4.46%
controls:1.27%
cases:7.30%
controls:2.27%
32
141
462
4799
17
70
477
4870
5
18
489
4922
—
11
20
482
4914
21
61
450
4751
29
94
368
4055
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.9e-01
7.3e-01
1.5e+00
2.1e+00
1.5e+00
6.9e-01
6.5e-01
cases:18.62%
controls:13.40%
cases:16.19%
controls:8.50%
cases:6.68%
controls:1.58%
cases:1.01%
controls:0.12%
cases:6.69%
controls:1.56%
cases:15.92%
controls:8.67%
cases:35.77%
controls:22.54%
92
662
402
4278
80
420
414
4520
33
78
461
4862
5
6
489
4934
33
77
460
4857
75
417
396
4395
142
935
255
3214
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
1.8e-01
7.6e-01
1.5e+00
—
1.3e+00
7.9e-01
6.8e-01
cases:10.32%
controls:8.81%
cases:10.12%
controls:5.00%
cases:2.63%
controls:0.61%
—
—
cases:2.64%
controls:0.71%
cases:10.62%
controls:5.09%
cases:28.97%
controls:17.11%
51
435
443
4505
50
247
444
4693
13
30
481
4910
—
13
35
480
4899
50
245
421
4567
115
710
282
3439
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
3.6e-01
1.1e+00
2.0e+00
—
2.0e+00
1.2e+00
7.4e-01
cases:2.43%
controls:1.70%
cases:3.44%
controls:1.15%
cases:1.01%
controls:0.14%
—
—
cases:1.22%
controls:0.16%
cases:3.61%
controls:1.16%
cases:9.57%
controls:4.82%
12
84
482
4856
17
57
477
4883
5
7
489
4933
—
6
8
487
4926
17
56
454
4756
38
200
359
3949
Cardiology
6 [38004451]
6 [38004451]
4.6e-01
7.7e-01
1.5e+00
—
1.2e+00
6.3e-01
5.6e-01
cases:18.42%
controls:12.53%
cases:11.74%
controls:5.81%
cases:3.85%
controls:0.91%
—
—
cases:2.84%
controls:0.91%
cases:10.62%
controls:5.96%
cases:21.16%
controls:13.30%
91
619
403
4321
58
287
436
4653
19
45
475
4895
—
14
45
479
4889
50
287
421
4525
84
552
313
3597
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
9.3e-01
1.8e+00
—
1.0e+50
—
1.5e+00
1.8e+00
cases:1.82%
controls:0.73%
cases:2.83%
controls:0.49%
—
—
cases:1.01%
controls:0.00%
—
—
cases:2.55%
controls:0.60%
cases:8.31%
controls:1.49%
9
36
485
4904
14
24
480
4916
—
5
0
489
4940
—
12
29
459
4783
33
62
364
4087
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
9.0e-01
1.8e+00
—
1.0e+50
—
1.5e+00
1.8e+00
cases:1.82%
controls:0.75%
cases:2.83%
controls:0.49%
—
—
cases:1.21%
controls:0.00%
—
—
cases:2.55%
controls:0.60%
cases:8.56%
controls:1.57%
9
37
485
4903
14
24
480
4916
—
6
0
488
4940
—
12
29
459
4783
34
65
363
4084
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
3.5e-01
7.5e-01
1.9e+00
—
1.7e+00
8.4e-01
4.9e-01
cases:3.24%
controls:2.31%
cases:4.66%
controls:2.25%
cases:1.82%
controls:0.26%
—
—
cases:1.62%
controls:0.30%
cases:6.16%
controls:2.76%
cases:19.40%
controls:12.82%
16
114
478
4826
23
111
471
4829
9
13
485
4927
—
8
15
485
4919
29
133
442
4679
77
532
320
3617
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
3.8e-01
6.7e-01
1.5e+00
—
1.6e+00
5.8e-01
6.7e-01
cases:18.02%
controls:13.02%
cases:14.98%
controls:8.26%
cases:6.07%
controls:1.48%
—
—
cases:6.49%
controls:1.42%
cases:14.44%
controls:8.62%
cases:35.26%
controls:21.86%
89
643
405
4297
74
408
420
4532
30
73
464
4867
—
32
70
461
4864
68
415
403
4397
140
907
257
3242
Sepsis due to Staphylococcus aureus
A41.0 [45532832]
A41.0 [45532832]
2.6e+00
—
—
—
—
—
2.4e+00
cases:1.82%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.76%
controls:0.17%
9
7
485
4933
—
—
—
—
—
7
7
390
4142
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.7e-01
6.8e-01
1.5e+00
2.3e+00
1.5e+00
6.1e-01
6.5e-01
cases:18.22%
controls:13.30%
cases:15.99%
controls:8.81%
cases:6.48%
controls:1.58%
cases:1.01%
controls:0.10%
cases:6.90%
controls:1.62%
cases:15.50%
controls:9.04%
cases:36.78%
controls:23.21%
90
657
404
4283
79
435
415
4505
32
78
462
4862
5
5
489
4935
34
80
459
4854
73
435
398
4377
146
963
251
3186
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.8e-01
6.7e-01
1.5e+00
2.3e+00
1.5e+00
6.1e-01
6.6e-01
cases:18.42%
controls:13.34%
cases:15.99%
controls:8.85%
cases:6.48%
controls:1.58%
cases:1.01%
controls:0.10%
cases:6.90%
controls:1.62%
cases:15.50%
controls:9.04%
cases:37.03%
controls:23.33%
91
659
403
4281
79
437
415
4503
32
78
462
4862
5
5
489
4935
34
80
459
4854
73
435
398
4377
147
968
250
3181
EKG study
11524-6 [3013512]
11524-6 [3013512]
8.1e-01
9.8e-01
1.2e+00
—
1.4e+00
9.7e-01
6.7e-01
cases:16.80%
controls:8.28%
cases:12.15%
controls:4.92%
cases:2.02%
controls:0.63%
—
—
cases:2.43%
controls:0.59%
cases:12.31%
controls:5.05%
cases:24.18%
controls:14.08%
83
409
411
4531
60
243
434
4697
10
31
484
4909
—
12
29
481
4905
58
243
413
4569
96
584
301
3565
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
2.9e-01
1.1e+00
—
—
2.0e+00
1.0e+00
6.9e-01
cases:2.43%
controls:1.82%
cases:3.44%
controls:1.15%
—
—
—
—
cases:1.22%
controls:0.16%
cases:3.18%
controls:1.16%
cases:8.82%
controls:4.60%
12
90
482
4850
17
57
477
4883
—
—
6
8
487
4926
15
56
456
4756
35
191
362
3958
Addiction caused by alcohol UNS
F10.29 [2000501684]
F10.29 [2000501684]
2.7e+00
—
—
—
—
—
2.2e+00
cases:1.42%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.17%
7
5
487
4935
—
—
—
—
—
6
7
391
4142
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
1.9e-01
4.9e-01
1.7e+00
—
1.6e+00
9.3e-01
6.3e-01
cases:8.50%
controls:7.11%
cases:8.10%
controls:5.12%
cases:3.64%
controls:0.71%
—
—
cases:3.85%
controls:0.79%
cases:10.83%
controls:4.59%
cases:21.66%
controls:12.82%
42
351
452
4589
40
253
454
4687
18
35
476
4905
—
19
39
474
4895
51
221
420
4591
86
532
311
3617
Vacuum treatment of wound
TQW11 [2001310078]
TQW11 [2001310078]
2.0e+00
—
—
—
—
—
2.9e+00
cases:1.42%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:2.52%
controls:0.14%
7
10
487
4930
—
—
—
—
—
10
6
387
4143
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-5.6e-01
-4.8e-01
-2.5e-01
—
—
2.7e+00
2.6e+00
cases:18.02%
controls:27.77%
cases:8.10%
controls:12.47%
cases:1.01%
controls:1.30%
—
—
—
—
cases:8.92%
controls:0.62%
cases:19.90%
controls:1.74%
89
1372
405
3568
40
616
454
4324
5
64
489
4876
—
—
42
30
429
4782
79
72
318
4077
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
K08.1 [45591573]
1.2e+00
1.3e+00
—
1.0e+50
—
1.3e+00
1.0e+00
cases:4.86%
controls:1.58%
cases:2.43%
controls:0.65%
—
—
cases:1.42%
controls:0.00%
—
—
cases:3.18%
controls:0.89%
cases:7.56%
controls:2.82%
24
78
470
4862
12
32
482
4908
—
7
0
487
4940
—
15
43
456
4769
30
117
367
4032
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
3.9e-01
6.8e-01
1.4e+00
2.3e+00
1.5e+00
6.0e-01
6.4e-01
cases:19.23%
controls:13.91%
cases:16.40%
controls:9.05%
cases:6.68%
controls:1.66%
cases:1.01%
controls:0.10%
cases:6.90%
controls:1.68%
cases:15.71%
controls:9.31%
cases:37.53%
controls:24.03%
95
687
399
4253
81
447
413
4493
33
82
461
4858
5
5
489
4935
34
83
459
4851
74
448
397
4364
149
997
248
3152
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
4.2e-01
1.2e+00
1.2e+00
—
2.1e+00
8.1e-01
6.9e-01
cases:10.93%
controls:7.47%
cases:9.51%
controls:3.04%
cases:1.42%
controls:0.45%
—
—
cases:2.64%
controls:0.34%
cases:6.16%
controls:2.83%
cases:20.40%
controls:11.40%
54
369
440
4571
47
150
447
4790
7
22
487
4918
—
13
17
480
4917
29
136
442
4676
81
473
316
3676
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
51484-4 [3030981]
1.0e+00
1.6e+00
—
—
—
1.2e+00
9.6e-01
cases:3.04%
controls:1.13%
cases:2.63%
controls:0.55%
—
—
—
—
—
—
cases:3.18%
controls:1.00%
cases:7.81%
controls:3.13%
15
56
479
4884
13
27
481
4913
—
—
—
15
48
456
4764
31
130
366
4019
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
5.6e-01
1.1e+00
1.7e+00
1.0e+50
8.4e-01
7.2e-01
5.9e-01
cases:18.02%
controls:11.15%
cases:10.73%
controls:3.81%
cases:2.63%
controls:0.49%
cases:2.43%
controls:0.00%
cases:1.22%
controls:0.53%
cases:6.79%
controls:3.43%
cases:17.88%
controls:10.73%
89
551
405
4389
53
188
441
4752
13
24
481
4916
12
0
482
4940
6
26
487
4908
32
165
439
4647
71
445
326
3704
Split skin graft
ZZA00 [2001311610]
ZZA00 [2001311610]
2.6e+00
—
—
—
—
—
2.1e+00
cases:2.43%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:2.27%
controls:0.29%
12
9
482
4931
—
—
—
—
—
9
12
388
4137
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
5.8e-01
1.8e+00
—
1.0e+50
—
1.8e+00
1.1e+00
cases:2.83%
controls:1.60%
cases:3.44%
controls:0.57%
—
—
cases:1.42%
controls:0.00%
—
—
cases:3.82%
controls:0.67%
cases:5.54%
controls:1.98%
14
79
480
4861
17
28
477
4912
—
7
0
487
4940
—
18
32
453
4780
22
82
375
4067
Revision of wound of skin of lower limb
QDB05 [2001309969]
QDB05 [2001309969]
2.2e+00
—
—
—
—
—
2.5e+00
cases:1.62%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:2.52%
controls:0.22%
8
9
486
4931
—
—
—
—
—
10
9
387
4140
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.4e+00
1.8e+00
—
—
—
1.3e+00
1.5e+00
cases:6.07%
controls:1.58%
cases:2.83%
controls:0.49%
—
—
—
—
—
—
cases:2.12%
controls:0.60%
cases:6.05%
controls:1.45%
30
78
464
4862
14
24
480
4916
—
—
—
10
29
461
4783
24
60
373
4089
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
9.2e-01
9.2e-01
1.3e+00
—
1.2e+00
9.0e-01
5.9e-01
cases:18.22%
controls:8.18%
cases:8.50%
controls:3.58%
cases:2.63%
controls:0.71%
—
—
cases:2.23%
controls:0.71%
cases:6.79%
controls:2.89%
cases:13.60%
controls:8.00%
90
404
404
4536
42
177
452
4763
13
35
481
4905
—
11
35
482
4899
32
139
439
4673
54
332
343
3817
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
7.6e-01
6.5e-01
1.7e+00
1.0e+50
1.7e+00
1.0e+00
1.2e+00
cases:8.30%
controls:4.05%
cases:3.44%
controls:1.82%
cases:1.62%
controls:0.30%
cases:1.01%
controls:0.00%
cases:1.42%
controls:0.26%
cases:5.31%
controls:1.93%
cases:13.85%
controls:4.82%
41
200
453
4740
17
90
477
4850
8
15
486
4925
5
0
489
4940
7
13
486
4921
25
93
446
4719
55
200
342
3949
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.8e-01
2.8e-01
9.3e-01
2.9e+00
7.9e-01
1.4e-01
1.6e-01
cases:47.57%
controls:40.57%
cases:22.27%
controls:17.85%
cases:6.28%
controls:2.57%
cases:1.82%
controls:0.10%
cases:5.68%
controls:2.66%
cases:19.53%
controls:17.37%
cases:42.82%
controls:38.90%
235
2004
259
2936
110
882
384
4058
31
127
463
4813
9
5
485
4935
28
131
465
4803
92
836
379
3976
170
1614
227
2535
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.8e-01
2.8e-01
9.3e-01
2.9e+00
7.9e-01
1.4e-01
1.6e-01
cases:47.57%
controls:40.57%
cases:22.27%
controls:17.85%
cases:6.28%
controls:2.57%
cases:1.82%
controls:0.10%
cases:5.68%
controls:2.66%
cases:19.53%
controls:17.37%
cases:42.82%
controls:38.90%
235
2004
259
2936
110
882
384
4058
31
127
463
4813
9
5
485
4935
28
131
465
4803
92
836
379
3976
170
1614
227
2535
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1961-2 [3015235]
—
2.5e+00
—
—
—
2.1e+00
1.0e+00
—
—
cases:1.21%
controls:0.10%
—
—
—
—
—
—
cases:1.70%
controls:0.21%
cases:3.53%
controls:1.33%
—
6
5
488
4935
—
—
—
8
10
463
4802
14
55
383
4094
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
1.8e-01
8.4e-01
1.7e+00
1.0e+50
1.3e+00
1.1e+00
9.7e-01
cases:7.69%
controls:6.48%
cases:5.87%
controls:2.63%
cases:1.82%
controls:0.32%
cases:1.42%
controls:0.00%
cases:1.62%
controls:0.43%
cases:5.94%
controls:2.16%
cases:15.62%
controls:6.53%
38
320
456
4620
29
130
465
4810
9
16
485
4924
7
0
487
4940
8
21
485
4913
28
104
443
4708
62
271
335
3878
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
1.5e+00
1.0e+00
—
—
—
1.0e+00
1.0e+00
cases:6.28%
controls:1.50%
cases:2.83%
controls:1.01%
—
—
—
—
—
—
cases:3.18%
controls:1.18%
cases:7.81%
controls:2.89%
31
74
463
4866
14
50
480
4890
—
—
—
15
57
456
4755
31
120
366
4029
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 [2001700354]
SPAT1253 [2001700354]
8.2e-01
8.6e-01
1.1e+00
—
9.5e-01
9.1e-01
8.6e-01
cases:18.42%
controls:9.03%
cases:7.89%
controls:3.50%
cases:2.83%
controls:0.95%
—
—
cases:2.23%
controls:0.87%
cases:7.43%
controls:3.12%
cases:13.85%
controls:6.36%
91
446
403
4494
39
173
455
4767
14
47
480
4893
—
11
43
482
4891
35
150
436
4662
55
264
342
3885
General symptom/complaint other
A29 [2002000163]
A29 [2002000163]
6.6e-01
7.1e-01
—
—
2.7e+00
1.1e+00
7.8e-01
cases:5.06%
controls:2.67%
cases:2.43%
controls:1.21%
—
—
—
—
cases:1.42%
controls:0.10%
cases:3.61%
controls:1.18%
cases:7.05%
controls:3.37%
25
132
469
4808
12
60
482
4880
—
—
7
5
486
4929
17
57
454
4755
28
140
369
4009
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
8.6e-01
1.1e+00
—
—
—
1.4e+00
1.1e+00
cases:7.29%
controls:3.22%
cases:4.66%
controls:1.56%
—
—
—
—
—
—
cases:5.10%
controls:1.25%
cases:12.09%
controls:4.31%
36
159
458
4781
23
77
471
4863
—
—
—
24
60
447
4752
48
179
349
3970
Prick test
37968009 [4242723]
37968009 [4242723]
7.8e-01
1.7e+00
—
—
—
2.7e+00
1.9e+00
cases:1.62%
controls:0.75%
cases:1.01%
controls:0.18%
—
—
—
—
—
—
cases:1.49%
controls:0.10%
cases:2.27%
controls:0.36%
8
37
486
4903
5
9
489
4931
—
—
—
7
5
464
4807
9
15
388
4134
Physical abuse
T74.1 [45594864]
T74.1 [45594864]
2.0e+00
—
—
—
—
—
2.5e+00
cases:1.21%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.17%
6
8
488
4932
—
—
—
—
—
8
7
389
4142
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
5.2e-01
8.1e-01
6.4e-01
—
1.5e+00
7.4e-01
9.8e-01
cases:16.80%
controls:10.69%
cases:10.12%
controls:4.76%
cases:1.42%
controls:0.75%
—
—
cases:2.64%
controls:0.63%
cases:8.28%
controls:4.11%
cases:24.69%
controls:10.99%
83
528
411
4412
50
235
444
4705
7
37
487
4903
—
13
31
480
4903
39
198
432
4614
98
456
299
3693
Decubitus ulcer and pressure area
L89 [45601235]
L89 [45601235]
2.5e+00
—
—
—
—
—
2.0e+00
cases:1.42%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:2.52%
controls:0.34%
7
6
487
4934
—
—
—
—
—
10
14
387
4135
Sampling
SPAT1263 [2001700364]
SPAT1263 [2001700364]
6.8e-01
8.6e-01
1.1e+00
—
9.2e-01
1.0e+00
7.8e-01
cases:24.09%
controls:13.81%
cases:12.35%
controls:5.63%
cases:3.44%
controls:1.13%
—
—
cases:3.04%
controls:1.24%
cases:13.80%
controls:5.42%
cases:23.68%
controls:12.44%
119
682
375
4258
61
278
433
4662
17
56
477
4884
—
15
61
478
4873
65
261
406
4551
94
516
303
3633
Chronic kidney disease
N18 [45582391]
N18 [45582391]
2.3e+00
—
—
—
—
—
2.2e+00
cases:1.62%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:2.27%
controls:0.27%
8
8
486
4932
—
—
—
—
—
9
11
388
4138
Neurology
13 [38004458]
13 [38004458]
5.2e-01
1.0e+00
8.2e-01
—
1.0e+00
1.0e+00
8.9e-01
cases:18.22%
controls:11.72%
cases:12.75%
controls:5.06%
cases:2.23%
controls:0.99%
—
—
cases:3.04%
controls:1.09%
cases:12.74%
controls:5.11%
cases:23.43%
controls:11.16%
90
579
404
4361
63
250
431
4690
11
49
483
4891
—
15
54
478
4880
60
246
411
4566
93
463
304
3686
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
2.7e-01
5.8e-01
1.2e+00
—
1.3e+00
6.9e-01
6.2e-01
cases:20.24%
controls:16.30%
cases:18.62%
controls:11.36%
cases:9.51%
controls:2.94%
—
—
cases:8.92%
controls:2.61%
cases:19.53%
controls:10.89%
cases:40.05%
controls:26.44%
100
805
394
4135
92
561
402
4379
47
145
447
4795
—
44
129
449
4805
92
524
379
4288
159
1097
238
3052
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
9.0e-01
1.1e+00
9.2e-01
—
1.3e+00
1.1e+00
1.2e+00
cases:3.85%
controls:1.60%
cases:3.04%
controls:1.01%
cases:1.01%
controls:0.40%
—
—
cases:1.42%
controls:0.41%
cases:3.40%
controls:1.12%
cases:5.54%
controls:1.66%
19
79
475
4861
15
50
479
4890
5
20
489
4920
—
7
20
486
4914
16
54
455
4758
22
69
375
4080
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
3.7e-01
8.3e-01
—
—
2.0e+00
9.3e-01
6.7e-01
cases:13.97%
controls:10.04%
cases:5.26%
controls:2.37%
—
—
—
—
cases:1.42%
controls:0.20%
cases:5.94%
controls:2.43%
cases:14.86%
controls:8.17%
69
496
425
4444
26
117
468
4823
—
—
7
10
486
4924
28
117
443
4695
59
339
338
3810
Sepsis, unspecified
A41.9 [45585911]
A41.9 [45585911]
2.1e+00
—
—
—
—
—
2.2e+00
cases:2.02%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.22%
10
12
484
4928
—
—
—
—
—
8
9
389
4140
Open wound of other parts of foot
S91.3 [45599027]
S91.3 [45599027]
1.9e+00
—
—
1.0e+50
—
1.0e+50
2.5e+00
cases:1.42%
controls:0.22%
—
—
—
—
cases:2.63%
controls:0.00%
—
—
cases:1.27%
controls:0.00%
cases:1.76%
controls:0.14%
7
11
487
4929
—
—
13
0
481
4940
—
6
0
465
4812
7
6
390
4143
fusidic acid
D09AA02 [21602265]
D09AA02 [21602265]
6.9e-01
8.8e-01
2.8e+00
—
—
1.0e+00
4.6e-01
cases:8.30%
controls:4.35%
cases:4.05%
controls:1.72%
cases:1.62%
controls:0.10%
—
—
—
—
cases:2.97%
controls:1.10%
cases:8.31%
controls:5.40%
41
215
453
4725
20
85
474
4855
8
5
486
4935
—
—
14
53
457
4759
33
224
364
3925
fusidic acid; ointment
D06AX01 [21602062]
D06AX01 [21602062]
6.9e-01
8.8e-01
2.8e+00
—
—
1.0e+00
4.6e-01
cases:8.30%
controls:4.35%
cases:4.05%
controls:1.72%
cases:1.62%
controls:0.10%
—
—
—
—
cases:2.97%
controls:1.10%
cases:8.31%
controls:5.40%
41
215
453
4725
20
85
474
4855
8
5
486
4935
—
—
14
53
457
4759
33
224
364
3925
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
3.7e-01
4.9e-01
1.0e+00
—
1.4e+00
5.3e-01
5.3e-01
cases:26.72%
controls:20.04%
cases:15.18%
controls:9.88%
cases:4.05%
controls:1.48%
—
—
cases:6.29%
controls:1.70%
cases:16.77%
controls:10.60%
cases:37.53%
controls:26.03%
132
990
362
3950
75
488
419
4452
20
73
474
4867
—
31
84
462
4850
79
510
392
4302
149
1080
248
3069
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.5e-01
5.8e-01
1.2e+00
—
1.2e+00
5.1e-01
4.8e-01
cases:31.58%
controls:24.53%
cases:21.26%
controls:13.10%
cases:5.67%
controls:1.86%
—
—
cases:5.48%
controls:1.68%
cases:20.38%
controls:13.34%
cases:46.35%
controls:34.83%
156
1212
338
3728
105
647
389
4293
28
92
466
4848
—
27
83
466
4851
96
642
375
4170
184
1445
213
2704
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
2.0e+00
2.2e+00
—
—
—
1.4e+00
6.3e-01
cases:3.64%
controls:0.51%
cases:2.23%
controls:0.24%
—
—
—
—
—
—
cases:1.91%
controls:0.46%
cases:4.03%
controls:2.19%
18
25
476
4915
11
12
483
4928
—
—
—
9
22
462
4790
16
91
381
4058
Supporting bandage or orthosis of lower limb
TNX92 [2001308571]
TNX92 [2001308571]
2.0e+00
—
—
—
—
—
2.2e+00
cases:1.21%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.17%
6
8
488
4932
—
—
—
—
—
6
7
391
4142
Patella X-ray examination
NG2AA [2001308078]
NG2AA [2001308078]
2.0e+00
—
—
—
—
—
2.2e+00
cases:1.21%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.17%
6
8
488
4932
—
—
—
—
—
6
7
391
4142
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
6.0e-01
8.9e-01
1.0e+00
—
1.5e+00
6.6e-01
6.0e-01
cases:17.21%
controls:10.28%
cases:12.96%
controls:5.77%
cases:2.43%
controls:0.91%
—
—
cases:3.85%
controls:0.91%
cases:11.04%
controls:6.05%
cases:28.46%
controls:17.91%
85
508
409
4432
64
285
430
4655
12
45
482
4895
—
19
45
474
4889
52
291
419
4521
113
743
284
3406
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
1.3e+00
2.5e+00
—
—
—
—
1.7e+00
cases:1.82%
controls:0.49%
cases:1.42%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.36%
9
24
485
4916
7
6
487
4934
—
—
—
—
8
15
389
4134
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
SPAT1222 [2001700323]
9.7e-01
1.2e+00
9.9e-01
—
9.3e-01
1.2e+00
9.2e-01
cases:6.88%
controls:2.71%
cases:4.05%
controls:1.32%
cases:1.62%
controls:0.61%
—
—
cases:1.62%
controls:0.65%
cases:4.46%
controls:1.45%
cases:7.30%
controls:3.04%
34
134
460
4806
20
65
474
4875
8
30
486
4910
—
8
32
485
4902
21
70
450
4742
29
126
368
4023
Urology
34 [38004474]
34 [38004474]
4.0e-01
8.0e-01
1.6e+00
—
1.2e+00
5.5e-01
5.7e-01
cases:12.35%
controls:8.62%
cases:8.30%
controls:3.91%
cases:3.24%
controls:0.69%
—
—
cases:2.64%
controls:0.77%
cases:6.79%
controls:4.05%
cases:13.60%
controls:8.19%
61
426
433
4514
41
193
453
4747
16
34
478
4906
—
13
38
480
4896
32
195
439
4617
54
340
343
3809
Hypersensitivity skin testing
268377001 [4147813]
268377001 [4147813]
8.6e-01
1.8e+00
—
—
—
2.7e+00
1.5e+00
cases:1.62%
controls:0.69%
cases:1.01%
controls:0.16%
—
—
—
—
—
—
cases:2.12%
controls:0.15%
cases:2.52%
controls:0.58%
8
34
486
4906
5
8
489
4932
—
—
—
10
7
461
4805
10
24
387
4125
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
4.5e-01
4.0e-01
1.2e+00
—
1.8e+00
1.4e+00
1.0e+00
cases:4.05%
controls:2.63%
cases:2.63%
controls:1.78%
cases:1.21%
controls:0.36%
—
—
cases:1.42%
controls:0.24%
cases:4.67%
controls:1.25%
cases:10.08%
controls:3.90%
20
130
474
4810
13
88
481
4852
6
18
488
4922
—
7
12
486
4922
22
60
449
4752
40
162
357
3987
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
3.1e-01
5.8e-01
1.2e+00
—
1.0e+00
6.7e-01
6.9e-01
cases:46.15%
controls:38.60%
cases:26.72%
controls:17.00%
cases:8.30%
controls:2.75%
—
—
cases:6.90%
controls:2.55%
cases:24.63%
controls:14.30%
cases:37.53%
controls:23.23%
228
1907
266
3033
132
840
362
4100
41
136
453
4804
—
34
126
459
4808
116
688
355
4124
149
964
248
3185
Acute renal failure, unspecified
N17.9 [45567829]
N17.9 [45567829]
1.9e+00
1.8e+00
—
—
—
—
2.2e+00
cases:1.62%
controls:0.24%
cases:1.21%
controls:0.20%
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.34%
8
12
486
4928
6
10
488
4930
—
—
—
—
12
14
385
4135
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
2639-3 [3005895]
9.8e-01
1.9e+00
—
—
—
2.2e+00
9.2e-01
cases:1.82%
controls:0.69%
cases:1.42%
controls:0.22%
—
—
—
—
—
—
cases:1.91%
controls:0.21%
cases:3.02%
controls:1.23%
9
34
485
4906
7
11
487
4929
—
—
—
9
10
462
4802
12
51
385
4098
Assessment of need for aid
SPAT1229 [2001700330]
SPAT1229 [2001700330]
1.1e+00
1.7e+00
—
—
—
1.2e+00
1.2e+00
cases:3.44%
controls:1.13%
cases:2.02%
controls:0.36%
—
—
—
—
—
—
cases:1.91%
controls:0.60%
cases:3.78%
controls:1.13%
17
56
477
4884
10
18
484
4922
—
—
—
9
29
462
4783
15
47
382
4102
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
7.7e-01
1.0e+00
1.4e+00
—
—
1.2e+00
1.1e+00
cases:6.28%
controls:3.02%
cases:4.45%
controls:1.62%
cases:1.21%
controls:0.30%
—
—
—
—
cases:4.88%
controls:1.50%
cases:11.84%
controls:4.41%
31
149
463
4791
22
80
472
4860
6
15
488
4925
—
—
23
72
448
4740
47
183
350
3966
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
6.2e-01
6.3e-01
1.4e+00
—
8.6e-01
6.9e-01
6.9e-01
cases:29.55%
controls:18.40%
cases:12.75%
controls:7.21%
cases:5.47%
controls:1.36%
—
—
cases:2.64%
controls:1.13%
cases:12.31%
controls:6.57%
cases:28.97%
controls:17.04%
146
909
348
4031
63
356
431
4584
27
67
467
4873
—
13
56
480
4878
58
316
413
4496
115
707
282
3442
Snapping jaw
K07.60 [2000502791]
K07.60 [2000502791]
1.0e+00
—
—
—
—
2.5e+00
1.5e+00
cases:1.82%
controls:0.67%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.10%
cases:3.53%
controls:0.80%
9
33
485
4907
—
—
—
—
6
5
465
4807
14
33
383
4116
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
8.9e-01
9.7e-01
—
—
—
2.2e+00
1.8e+00
cases:3.44%
controls:1.44%
cases:1.21%
controls:0.47%
—
—
—
—
—
—
cases:2.97%
controls:0.33%
cases:7.81%
controls:1.40%
17
71
477
4869
6
23
488
4917
—
—
—
14
16
457
4796
31
58
366
4091
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
3.6e-01
6.4e-01
1.2e+00
—
1.2e+00
6.4e-01
3.8e-01
cases:25.91%
controls:19.60%
cases:17.61%
controls:10.10%
cases:4.05%
controls:1.32%
—
—
cases:4.87%
controls:1.54%
cases:16.99%
controls:9.70%
cases:40.81%
controls:32.08%
128
968
366
3972
87
499
407
4441
20
65
474
4875
—
24
76
469
4858
80
467
391
4345
162
1331
235
2818
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
1.7e+00
1.5e+00
—
—
—
—
2.2e+00
cases:1.82%
controls:0.32%
cases:1.01%
controls:0.22%
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.22%
9
16
485
4924
5
11
489
4929
—
—
—
—
8
9
389
4140
Pain general/multiple sites
A01 [2002000142]
A01 [2002000142]
1.2e+00
—
—
—
—
1.5e+00
1.2e+00
cases:3.85%
controls:1.13%
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.50%
cases:6.30%
controls:1.95%
19
56
475
4884
—
—
—
—
10
24
461
4788
25
81
372
4068
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
XPX99 [2001309755]
8.1e-01
1.6e+00
—
—
—
2.0e+00
1.9e+00
cases:2.02%
controls:0.91%
cases:1.42%
controls:0.28%
—
—
—
—
—
—
cases:2.12%
controls:0.29%
cases:4.28%
controls:0.65%
10
45
484
4895
7
14
487
4926
—
—
—
10
14
461
4798
17
27
380
4122
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
5.2e-01
8.5e-01
8.4e-01
—
1.4e+00
5.4e-01
6.1e-01
cases:17.81%
controls:11.40%
cases:14.57%
controls:6.82%
cases:2.63%
controls:1.15%
—
—
cases:4.46%
controls:1.16%
cases:12.53%
controls:7.69%
cases:38.54%
controls:25.36%
88
563
406
4377
72
337
422
4603
13
57
481
4883
—
22
57
471
4877
59
370
412
4442
153
1052
244
3097
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
87975-9 [36305247]
1.1e+00
—
—
—
—
2.1e+00
1.8e+00
cases:1.42%
controls:0.47%
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.25%
cases:4.79%
controls:0.80%
7
23
487
4917
—
—
—
—
9
12
462
4800
19
33
378
4116
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
3.1e-01
1.4e+00
—
1.0e+50
—
1.5e+00
1.0e+00
cases:2.43%
controls:1.80%
cases:2.83%
controls:0.73%
—
—
cases:1.21%
controls:0.00%
—
—
cases:2.97%
controls:0.71%
cases:5.04%
controls:1.83%
12
89
482
4851
14
36
480
4904
—
6
0
488
4940
—
14
34
457
4778
20
76
377
4073
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
4.8e-01
9.0e-01
1.6e+00
—
1.2e+00
7.8e-01
6.0e-01
cases:7.29%
controls:4.64%
cases:7.29%
controls:3.10%
cases:2.43%
controls:0.51%
—
—
cases:2.03%
controls:0.65%
cases:6.58%
controls:3.14%
cases:17.38%
controls:10.32%
36
229
458
4711
36
153
458
4787
12
25
482
4915
—
10
32
483
4902
31
151
440
4661
69
428
328
3721
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-7.5e-02
9.6e-03
1.3e+00
—
1.3e+00
4.9e-01
8.2e-01
cases:9.92%
controls:10.61%
cases:9.31%
controls:9.23%
cases:6.48%
controls:1.88%
—
—
cases:6.29%
controls:1.84%
cases:15.50%
controls:10.10%
cases:38.29%
controls:21.45%
49
524
445
4416
46
456
448
4484
32
93
462
4847
—
31
91
462
4843
73
486
398
4326
152
890
245
3259
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
5.1e-01
8.2e-01
8.8e-01
—
1.4e+00
5.6e-01
5.9e-01
cases:17.41%
controls:11.23%
cases:14.37%
controls:6.86%
cases:2.63%
controls:1.11%
—
—
cases:4.26%
controls:1.11%
cases:12.74%
controls:7.67%
cases:37.53%
controls:24.95%
86
555
408
4385
71
339
423
4601
13
55
481
4885
—
21
55
472
4879
60
369
411
4443
149
1035
248
3114
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
5.0e-01
8.2e-01
8.6e-01
—
1.4e+00
5.7e-01
6.0e-01
cases:18.02%
controls:11.74%
cases:14.78%
controls:7.11%
cases:2.63%
controls:1.13%
—
—
cases:4.46%
controls:1.18%
cases:12.95%
controls:7.77%
cases:38.54%
controls:25.55%
89
580
405
4360
73
351
421
4589
13
56
481
4884
—
22
58
471
4876
61
374
410
4438
153
1060
244
3089
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
8.7e-01
2.2e+00
—
—
—
2.0e+00
1.7e+00
cases:3.44%
controls:1.48%
cases:1.21%
controls:0.14%
—
—
—
—
—
—
cases:1.06%
controls:0.15%
cases:2.02%
controls:0.39%
17
73
477
4867
6
7
488
4933
—
—
—
5
7
466
4805
8
16
389
4133
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
8.7e-01
1.8e+00
—
—
—
9.8e-01
1.1e+00
cases:4.05%
controls:1.74%
cases:3.44%
controls:0.57%
—
—
—
—
—
—
cases:1.70%
controls:0.64%
cases:7.81%
controls:2.68%
20
86
474
4854
17
28
477
4912
—
—
—
8
31
463
4781
31
111
366
4038
Psychological disorders other
P99 [2002000880]
P99 [2002000880]
1.1e+00
2.1e+00
—
—
—
—
1.6e+00
cases:1.82%
controls:0.59%
cases:2.02%
controls:0.24%
—
—
—
—
—
—
—
—
cases:2.52%
controls:0.51%
9
29
485
4911
10
12
484
4928
—
—
—
—
10
21
387
4128
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
FM1EE [2001303307]
7.9e-01
1.2e+00
1.7e+00
—
—
9.3e-01
8.4e-01
cases:9.51%
controls:4.55%
cases:5.87%
controls:1.88%
cases:1.01%
controls:0.18%
—
—
—
—
cases:4.67%
controls:1.89%
cases:11.59%
controls:5.35%
47
225
447
4715
29
93
465
4847
5
9
489
4931
—
—
22
91
449
4721
46
222
351
3927
Constipation
K59.0 [45557663]
K59.0 [45557663]
2.0e+00
—
—
—
—
—
1.7e+00
cases:2.23%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.52%
controls:0.46%
11
15
483
4925
—
—
—
—
—
10
19
387
4130
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
3.6e-01
8.1e-01
1.3e+00
—
1.4e+00
8.5e-01
7.1e-01
cases:13.16%
controls:9.57%
cases:11.34%
controls:5.38%
cases:2.23%
controls:0.65%
—
—
cases:2.64%
controls:0.69%
cases:10.62%
controls:4.82%
cases:26.20%
controls:14.90%
65
473
429
4467
56
266
438
4674
11
32
483
4908
—
13
34
480
4900
50
232
421
4580
104
618
293
3531
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
1.9e-01
7.0e-01
1.4e+00
—
1.2e+00
8.4e-01
7.7e-01
cases:8.70%
controls:7.29%
cases:7.89%
controls:4.09%
cases:2.02%
controls:0.51%
—
—
cases:1.83%
controls:0.55%
cases:8.07%
controls:3.66%
cases:22.17%
controls:11.62%
43
360
451
4580
39
202
455
4738
10
25
484
4915
—
9
27
484
4907
38
176
433
4636
88
482
309
3667
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
6.8e-01
1.3e+00
—
1.0e+50
—
1.8e+00
1.9e+00
cases:3.24%
controls:1.66%
cases:1.82%
controls:0.51%
—
—
cases:1.42%
controls:0.00%
—
—
cases:1.91%
controls:0.31%
cases:5.29%
controls:0.84%
16
82
478
4858
9
25
485
4915
—
7
0
487
4940
—
9
15
462
4797
21
35
376
4114
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
1.0e+00
1.3e+00
—
—
—
1.7e+00
9.5e-01
cases:3.44%
controls:1.23%
cases:1.82%
controls:0.49%
—
—
—
—
—
—
cases:2.76%
controls:0.52%
cases:6.30%
controls:2.53%
17
61
477
4879
9
24
485
4916
—
—
—
13
25
458
4787
25
105
372
4044
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
4.9e-01
5.9e-01
2.1e+00
—
—
9.1e-01
6.8e-01
cases:7.89%
controls:4.98%
cases:3.04%
controls:1.70%
cases:1.62%
controls:0.20%
—
—
—
—
cases:4.03%
controls:1.66%
cases:10.58%
controls:5.66%
39
246
455
4694
15
84
479
4856
8
10
486
4930
—
—
19
80
452
4732
42
235
355
3914
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
Y83 [45552036]
1.2e+00
—
—
—
—
—
2.5e+00
cases:3.04%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
cases:2.52%
controls:0.22%
15
46
479
4894
—
—
—
—
—
10
9
387
4140
cetirizine; oral
R06AE07 [21603497]
R06AE07 [21603497]
1.5e-01
6.5e-01
1.2e+00
—
1.5e+00
7.9e-01
7.4e-01
cases:10.12%
controls:8.87%
cases:8.50%
controls:4.62%
cases:2.23%
controls:0.69%
—
—
cases:3.45%
controls:0.81%
cases:8.92%
controls:4.24%
cases:15.87%
controls:8.24%
50
438
444
4502
42
228
452
4712
11
34
483
4906
—
17
40
476
4894
42
204
429
4608
63
342
334
3807
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
8.7e-01
1.1e+00
—
—
—
1.9e+00
1.7e+00
cases:1.01%
controls:0.43%
cases:1.01%
controls:0.34%
—
—
—
—
—
—
cases:2.12%
controls:0.31%
cases:2.77%
controls:0.51%
5
21
489
4919
5
17
489
4923
—
—
—
10
15
461
4797
11
21
386
4128
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
8.7e-01
1.1e+00
—
—
—
1.9e+00
1.7e+00
cases:1.01%
controls:0.43%
cases:1.01%
controls:0.34%
—
—
—
—
—
—
cases:2.12%
controls:0.31%
cases:2.77%
controls:0.51%
5
21
489
4919
5
17
489
4923
—
—
—
10
15
461
4797
11
21
386
4128
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
8.7e-01
1.1e+00
—
—
—
1.9e+00
1.7e+00
cases:1.01%
controls:0.43%
cases:1.01%
controls:0.34%
—
—
—
—
—
—
cases:2.12%
controls:0.31%
cases:2.77%
controls:0.51%
5
21
489
4919
5
17
489
4923
—
—
—
10
15
461
4797
11
21
386
4128
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
4.2e-01
7.4e-01
8.9e-01
—
1.4e+00
6.9e-01
7.2e-01
cases:10.53%
controls:7.21%
cases:8.50%
controls:4.25%
cases:1.62%
controls:0.67%
—
—
cases:2.84%
controls:0.71%
cases:8.07%
controls:4.22%
cases:21.91%
controls:12.00%
52
356
442
4584
42
210
452
4730
8
33
486
4907
—
14
35
479
4899
38
203
433
4609
87
498
310
3651
ferrous glycine sulfate; oral
B03AA01 [21601080]
B03AA01 [21601080]
9.7e-01
1.3e+00
-1.0e+50
—
—
1.9e+00
1.6e+00
cases:2.63%
controls:1.01%
cases:1.62%
controls:0.45%
cases:0.00%
controls:0.14%
—
—
—
—
cases:2.76%
controls:0.42%
cases:6.05%
controls:1.25%
13
50
481
4890
8
22
486
4918
0
7
494
4933
—
—
13
20
458
4792
24
52
373
4097
Ophthalmology
18 [38004463]
18 [38004463]
3.5e-01
4.5e-01
4.2e-01
2.5e+00
4.6e-01
5.2e-01
5.4e-01
cases:22.87%
controls:17.31%
cases:10.93%
controls:7.27%
cases:2.23%
controls:1.48%
cases:1.42%
controls:0.12%
cases:2.64%
controls:1.68%
cases:12.53%
controls:7.81%
cases:28.46%
controls:18.75%
113
855
381
4085
54
359
440
4581
11
73
483
4867
7
6
487
4934
13
83
480
4851
59
376
412
4436
113
778
284
3371
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
3.9e-01
1.3e+00
—
1.0e+50
—
1.4e+00
8.6e-01
cases:3.04%
controls:2.09%
cases:3.24%
controls:0.93%
—
—
cases:1.42%
controls:0.00%
—
—
cases:3.61%
controls:0.94%
cases:8.31%
controls:3.71%
15
103
479
4837
16
46
478
4894
—
7
0
487
4940
—
17
45
454
4767
33
154
364
3995
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
6.1e-01
1.3e+00
—
—
—
1.2e+00
9.9e-01
cases:7.29%
controls:4.11%
cases:4.25%
controls:1.21%
—
—
—
—
—
—
cases:4.46%
controls:1.39%
cases:11.34%
controls:4.56%
36
203
458
4737
21
60
473
4880
—
—
—
21
67
450
4745
45
189
352
3960
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
8.7e-01
1.0e+00
—
—
2.3e+00
1.6e+00
1.0e+00
cases:5.47%
controls:2.37%
cases:1.42%
controls:0.51%
—
—
—
—
cases:1.01%
controls:0.10%
cases:3.18%
controls:0.69%
cases:6.55%
controls:2.48%
27
117
467
4823
7
25
487
4915
—
—
5
5
488
4929
15
33
456
4779
26
103
371
4046
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
7.0e-01
9.7e-01
1.8e+00
—
—
9.0e-01
6.9e-01
cases:5.06%
controls:2.57%
cases:3.44%
controls:1.34%
cases:1.42%
controls:0.24%
—
—
—
—
cases:2.76%
controls:1.14%
cases:8.31%
controls:4.36%
25
127
469
4813
17
66
477
4874
7
12
487
4928
—
—
13
55
458
4757
33
181
364
3968
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
SPAT1156 [2001700257]
1.1e+00
9.5e-01
1.1e+00
—
1.5e+00
1.3e+00
9.8e-01
cases:7.09%
controls:2.37%
cases:2.23%
controls:0.87%
cases:1.21%
controls:0.40%
—
—
cases:1.22%
controls:0.28%
cases:3.18%
controls:0.89%
cases:5.54%
controls:2.15%
35
117
459
4823
11
43
483
4897
6
20
488
4920
—
6
14
487
4920
15
43
456
4769
22
89
375
4060
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
2.5e-01
9.2e-01
1.1e+00
1.0e+50
1.8e+00
6.3e-01
6.0e-01
cases:6.28%
controls:4.94%
cases:6.07%
controls:2.51%
cases:1.01%
controls:0.32%
cases:1.21%
controls:0.00%
cases:2.03%
controls:0.32%
cases:4.67%
controls:2.54%
cases:13.85%
controls:8.07%
31
244
463
4696
30
124
464
4816
5
16
489
4924
6
0
488
4940
10
16
483
4918
22
122
449
4690
55
335
342
3814
pH of Blood
11558-4 [3010421]
11558-4 [3010421]
7.0e-01
9.7e-01
—
—
—
1.9e+00
1.4e+00
cases:1.01%
controls:0.51%
cases:1.01%
controls:0.38%
—
—
—
—
—
—
cases:2.55%
controls:0.37%
cases:2.77%
controls:0.67%
5
25
489
4915
5
19
489
4921
—
—
—
12
18
459
4794
11
28
386
4121
Erysipelas
A46 [45561706]
A46 [45561706]
9.9e-01
1.3e+00
—
—
—
8.6e-01
1.1e+00
cases:5.87%
controls:2.27%
cases:3.04%
controls:0.83%
—
—
—
—
—
—
cases:2.34%
controls:1.00%
cases:7.30%
controls:2.65%
29
112
465
4828
15
41
479
4899
—
—
—
11
48
460
4764
29
110
368
4039
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1845-7 [3023183]
1.6e+00
1.8e+00
—
—
—
1.8e+00
1.6e+00
cases:1.42%
controls:0.30%
cases:1.42%
controls:0.24%
—
—
—
—
—
—
cases:1.27%
controls:0.21%
cases:3.78%
controls:0.80%
7
15
487
4925
7
12
487
4928
—
—
—
6
10
465
4802
15
33
382
4116
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
6.4e-01
5.5e-01
3.7e-01
-1.0e+50
9.0e-01
5.3e-01
7.4e-01
cases:16.60%
controls:9.47%
cases:13.16%
controls:8.06%
cases:3.24%
controls:2.27%
cases:0.00%
controls:0.12%
cases:4.87%
controls:2.05%
cases:13.59%
controls:8.46%
cases:20.40%
controls:10.89%
82
468
412
4472
65
398
429
4542
16
112
478
4828
0
6
494
4934
24
101
469
4833
64
407
407
4405
81
452
316
3697
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
8.8e-01
8.1e-01
6.3e-01
-1.0e+50
6.5e-01
7.5e-01
9.0e-01
cases:14.78%
controls:6.68%
cases:11.13%
controls:5.28%
cases:3.64%
controls:1.98%
cases:0.00%
controls:0.10%
cases:3.65%
controls:1.95%
cases:11.89%
controls:5.96%
cases:18.89%
controls:8.63%
73
330
421
4610
55
261
439
4679
18
98
476
4842
0
5
494
4935
18
96
475
4838
56
287
415
4525
75
358
322
3791
Intravenous administration of medicine
SPAT1255 [2001700356]
SPAT1255 [2001700356]
9.3e-01
2.0e+00
—
—
—
1.6e+00
1.3e+00
cases:2.63%
controls:1.05%
cases:2.02%
controls:0.28%
—
—
—
—
—
—
cases:1.49%
controls:0.31%
cases:3.53%
controls:0.96%
13
52
481
4888
10
14
484
4926
—
—
—
7
15
464
4797
14
40
383
4109
Unspecified nonorganic psychosis
F29 [45533099]
F29 [45533099]
1.3e+00
1.6e+00
—
—
—
2.0e+00
1.1e+00
cases:2.23%
controls:0.63%
cases:1.42%
controls:0.30%
—
—
—
—
—
—
cases:1.70%
controls:0.23%
cases:1.26%
controls:0.43%
11
31
483
4909
7
15
487
4925
—
—
—
8
11
463
4801
5
18
392
4131
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
4.7e-01
5.4e-01
3.8e-01
—
9.4e-01
7.3e-01
6.1e-01
cases:29.35%
controls:20.61%
cases:19.84%
controls:12.57%
cases:4.25%
controls:2.94%
—
—
cases:6.90%
controls:2.82%
cases:21.66%
controls:11.74%
cases:36.52%
controls:23.76%
145
1018
349
3922
98
621
396
4319
21
145
473
4795
—
34
139
459
4795
102
565
369
4247
145
986
252
3163
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
20578-1 [3005715]
1.7e+00
—
—
—
—
—
1.6e+00
cases:1.62%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.41%
8
15
486
4925
—
—
—
—
—
8
17
389
4132
Functional capacity evaluation
443351003 [40481051]
443351003 [40481051]
6.2e-01
9.5e-01
1.3e+00
—
—
1.3e+00
1.0e+00
cases:5.47%
controls:3.02%
cases:3.44%
controls:1.36%
cases:1.01%
controls:0.28%
—
—
—
—
cases:4.03%
controls:1.12%
cases:8.31%
controls:3.13%
27
149
467
4791
17
67
477
4873
5
14
489
4926
—
—
19
54
452
4758
33
130
364
4019
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
2.2e-01
1.2e+00
—
1.0e+50
—
1.3e+00
7.5e-01
cases:3.24%
controls:2.61%
cases:3.85%
controls:1.15%
—
—
cases:1.42%
controls:0.00%
—
—
cases:4.03%
controls:1.12%
cases:8.56%
controls:4.24%
16
129
478
4811
19
57
475
4883
—
7
0
487
4940
—
19
54
452
4758
34
176
363
3973
Specific gravity of Urine by Test strip
5811-5 [3000330]
5811-5 [3000330]
1.7e+00
1.6e+00
—
—
—
8.0e-01
7.3e-01
cases:4.66%
controls:0.87%
cases:3.04%
controls:0.65%
—
—
—
—
—
—
cases:1.70%
controls:0.77%
cases:5.79%
controls:2.89%
23
43
471
4897
15
32
479
4908
—
—
—
8
37
463
4775
23
120
374
4029
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
3.4e-01
1.2e+00
—
1.0e+50
—
1.2e+00
7.9e-01
cases:2.63%
controls:1.88%
cases:3.04%
controls:0.91%
—
—
cases:1.42%
controls:0.00%
—
—
cases:2.97%
controls:0.87%
cases:7.81%
controls:3.69%
13
93
481
4847
15
45
479
4895
—
7
0
487
4940
—
14
42
457
4770
31
153
366
3996
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
33863-2 [3030366]
8.4e-01
1.5e+00
—
—
—
1.9e+00
1.3e+00
cases:1.21%
controls:0.53%
cases:1.42%
controls:0.32%
—
—
—
—
—
—
cases:2.12%
controls:0.31%
cases:3.27%
controls:0.89%
6
26
488
4914
7
16
487
4924
—
—
—
10
15
461
4797
13
37
384
4112
Persistent somatoform pain disorder
F45.4 [45605498]
F45.4 [45605498]
—
—
—
—
—
—
3.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.12%
—
—
—
—
—
—
12
5
385
4144
hydrocortisone
S02BA01 [21605166]
S02BA01 [21605166]
6.6e-01
7.5e-01
2.0e+00
—
—
2.7e-01
5.5e-01
cases:11.74%
controls:6.42%
cases:4.45%
controls:2.15%
cases:1.21%
controls:0.16%
—
—
—
—
cases:2.97%
controls:2.29%
cases:12.59%
controls:7.69%
58
317
436
4623
22
106
472
4834
6
8
488
4932
—
—
14
110
457
4702
50
319
347
3830
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
2.4e-01
1.3e+00
—
1.0e+50
—
1.3e+00
6.9e-01
cases:3.24%
controls:2.57%
cases:3.85%
controls:1.11%
—
—
cases:1.42%
controls:0.00%
—
—
cases:3.82%
controls:1.10%
cases:8.06%
controls:4.19%
16
127
478
4813
19
55
475
4885
—
7
0
487
4940
—
18
53
453
4759
32
174
365
3975
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
2.4e-01
1.3e+00
—
1.0e+50
—
1.3e+00
6.9e-01
cases:3.24%
controls:2.57%
cases:3.85%
controls:1.11%
—
—
cases:1.42%
controls:0.00%
—
—
cases:3.82%
controls:1.10%
cases:8.06%
controls:4.22%
16
127
478
4813
19
55
475
4885
—
7
0
487
4940
—
18
53
453
4759
32
175
365
3974
Concussion
S06.0 [45582805]
S06.0 [45582805]
1.3e+00
1.9e+00
—
—
—
—
8.5e-01
cases:4.25%
controls:1.19%
cases:2.02%
controls:0.30%
—
—
—
—
—
—
—
—
cases:2.77%
controls:1.21%
21
59
473
4881
10
15
484
4925
—
—
—
—
11
50
386
4099
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
3.7e-01
4.4e-01
4.6e-01
—
1.1e+00
9.1e-01
7.9e-01
cases:36.23%
controls:28.26%
cases:15.59%
controls:10.63%
cases:2.63%
controls:1.68%
—
—
cases:3.85%
controls:1.32%
cases:21.66%
controls:10.02%
cases:48.87%
controls:30.27%
179
1396
315
3544
77
525
417
4415
13
83
481
4857
—
19
65
474
4869
102
482
369
4330
194
1256
203
2893
ciclesonide; nasal
R01AD13 [43534836]
R01AD13 [43534836]
1.2e+00
1.0e+00
1.2e+00
—
—
7.6e-01
9.8e-01
cases:5.26%
controls:1.70%
cases:3.44%
controls:1.28%
cases:1.01%
controls:0.30%
—
—
—
—
cases:2.76%
controls:1.31%
cases:5.29%
controls:2.05%
26
84
468
4856
17
63
477
4877
5
15
489
4925
—
—
13
63
458
4749
21
85
376
4064
ciclesonide; inhalant
R03BA08 [21603291]
R03BA08 [21603291]
1.2e+00
1.0e+00
1.2e+00
—
—
7.6e-01
9.8e-01
cases:5.26%
controls:1.70%
cases:3.44%
controls:1.28%
cases:1.01%
controls:0.30%
—
—
—
—
cases:2.76%
controls:1.31%
cases:5.29%
controls:2.05%
26
84
468
4856
17
63
477
4877
5
15
489
4925
—
—
13
63
458
4749
21
85
376
4064
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
3.7e-01
4.1e-01
6.3e-01
—
1.9e+00
7.1e-01
5.6e-01
cases:13.36%
controls:9.66%
cases:9.11%
controls:6.21%
cases:2.23%
controls:1.19%
—
—
cases:4.46%
controls:0.71%
cases:13.59%
controls:7.15%
cases:34.76%
controls:23.31%
66
477
428
4463
45
307
449
4633
11
59
483
4881
—
22
35
471
4899
64
344
407
4468
138
967
259
3182
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
6.5e-01
9.7e-01
7.4e-01
—
1.5e+00
3.4e-01
3.0e-01
cases:7.89%
controls:4.27%
cases:6.68%
controls:2.63%
cases:1.01%
controls:0.49%
—
—
cases:1.83%
controls:0.41%
cases:4.67%
controls:3.37%
cases:18.14%
controls:14.08%
39
211
455
4729
33
130
461
4810
5
24
489
4916
—
9
20
484
4914
22
162
449
4650
72
584
325
3565
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
1.0e-02
2.9e-01
—
—
2.1e+00
1.0e+00
2.3e-01
cases:6.48%
controls:6.42%
cases:3.24%
controls:2.45%
—
—
—
—
cases:1.62%
controls:0.20%
cases:4.67%
controls:1.70%
cases:7.30%
controls:5.91%
32
317
462
4623
16
121
478
4819
—
—
8
10
485
4924
22
82
449
4730
29
245
368
3904
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
3.8e-01
1.1e+00
1.6e+00
—
1.8e+00
1.0e+00
9.7e-01
cases:5.47%
controls:3.79%
cases:4.25%
controls:1.44%
cases:1.01%
controls:0.20%
—
—
cases:1.01%
controls:0.16%
cases:3.61%
controls:1.31%
cases:11.84%
controls:4.84%
27
187
467
4753
21
71
473
4869
5
10
489
4930
—
5
8
488
4926
17
63
454
4749
47
201
350
3948
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
1.1e+00
1.7e+00
—
—
—
1.4e+00
4.9e-01
cases:1.82%
controls:0.59%
cases:2.02%
controls:0.38%
—
—
—
—
—
—
cases:2.34%
controls:0.56%
cases:3.02%
controls:1.88%
9
29
485
4911
10
19
484
4921
—
—
—
11
27
460
4785
12
78
385
4071
Depressive disorder
P76 [2002000870]
P76 [2002000870]
9.1e-01
1.7e+00
—
—
—
1.4e+00
1.4e+00
cases:2.43%
controls:0.99%
cases:2.02%
controls:0.36%
—
—
—
—
—
—
cases:1.70%
controls:0.44%
cases:5.29%
controls:1.42%
12
49
482
4891
10
18
484
4922
—
—
—
8
21
463
4791
21
59
376
4090
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
546-2 [3024135]
3.9e-01
-1.1e-01
2.4e+00
—
—
-5.7e-04
6.1e-01
cases:7.89%
controls:5.47%
cases:1.82%
controls:2.02%
cases:1.82%
controls:0.16%
—
—
—
—
cases:1.91%
controls:1.91%
cases:12.85%
controls:7.40%
39
270
455
4670
9
100
485
4840
9
8
485
4932
—
—
9
92
462
4720
51
307
346
3842
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
3.5e-01
6.0e-01
—
—
1.9e+00
1.1e+00
3.3e-01
cases:9.11%
controls:6.58%
cases:3.85%
controls:2.15%
—
—
—
—
cases:1.83%
controls:0.28%
cases:4.88%
controls:1.60%
cases:8.06%
controls:5.91%
45
325
449
4615
19
106
475
4834
—
—
9
14
484
4920
23
77
448
4735
32
245
365
3904
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
7.2e-01
8.1e-01
1.1e+00
—
1.4e+00
8.6e-01
6.3e-01
cases:10.73%
controls:5.51%
cases:7.69%
controls:3.58%
cases:1.82%
controls:0.59%
—
—
cases:1.83%
controls:0.47%
cases:7.64%
controls:3.39%
cases:18.89%
controls:11.04%
53
272
441
4668
38
177
456
4763
9
29
485
4911
—
9
23
484
4911
36
163
435
4649
75
458
322
3691
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
9.6e-01
1.1e+00
—
—
1.8e+00
8.3e-01
9.9e-01
cases:13.77%
controls:5.75%
cases:5.47%
controls:1.94%
—
—
—
—
cases:1.22%
controls:0.20%
cases:3.61%
controls:1.60%
cases:11.34%
controls:4.56%
68
284
426
4656
27
96
467
4844
—
—
6
10
487
4924
17
77
454
4735
45
189
352
3960
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
320
1898
2.95
28.96
18.9
12.6
1.21
1.21
inr
0.01
289
1579
107
361
3.51
26.26
13.1
7.0
9.92
9.41
mmol/l
0.27
100
343
245
1367
2.57
23.34
5.3
2.6
50.95
62.63
u/l
2.47
239
1281
321
2086
2.54
21.35
16.1
6.9
1.21
1.21
mmol/l
0.28
293
1814
68
195
3.88
21.03
7.5
3.3
25.42
24.95
mmol/l
0.54
63
188
33
52
6.73
20.35
3.0
2.8
4.05
3.97
mmol/l
0.50
33
52
33
52
6.73
20.35
3.0
2.8
105.82
105.27
mmol/l
0.20
33
52
106
417
2.96
19.74
10.7
3.5
1.68
1.75
mmol/l
0.07
93
355
334
2256
2.48
19.70
9.4
6.8
9.64
11.46
umol/l
2.95
326
2155
127
559
2.71
19.09
13.5
5.9
1.12
1.04
mmol/l
1.89
120
514
354
2482
2.50
18.80
10.1
4.8
6.97
6.62
mmol/l
2.27
348
2341
149
715
2.55
18.75
5.2
2.5
12.37
13.59
umol/l
0.98
140
672
76
254
3.35
18.61
8.4
6.4
24.27
24.34
mmol/l
0.05
69
242
283
1808
2.32
18.50
9.2
4.9
34.63
36.13
g/l
4.08
277
1713
141
666
2.56
18.29
5.3
2.5
2.31
2.34
g/l
0.21
131
622
127
584
2.58
17.31
8.8
6.9
103.93
104.16
mmol/l
0.17
127
584
130
608
2.54
17.08
5.4
2.5
22.17
23.68
%
0.45
120
574
79
285
3.11
16.99
2.4
1.6
—
—
—
0
0
302
2026
2.26
16.98
4.1
2.8
—
—
estimate
—
0
0
66
214
3.41
16.90
4.6
3.0
2.21
1.82
mmol/l
0.30
48
159
30
52
6.08
16.85
3.1
2.8
1.20
1.19
mmol/l
0.43
30
52
144
711
2.45
16.81
5.8
3.1
0.80
0.82
mmol/l
1.15
138
675
141
693
2.45
16.60
2.8
1.8
—
—
—
0
0
219
1299
2.23
16.60
3.0
2.1
192.77
242.08
u/l
0.38
214
1231
42
104
4.32
15.76
3.0
1.5
—
—
—
0
0
25
17
15.42
15.52
3.7
1.6
296.85
63.22
umol/l
—
13
9
162
869
2.29
15.46
2.0
1.7
458.01
22296824.25
pmol/l
0.72
150
749
241
1545
2.09
14.38
4.3
3.4
30.97
33.14
u/l
0.30
231
1473
130
654
2.34
14.28
1.9
1.6
1237.76
1194.60
nmol/l
0.20
109
500
410
3246
2.55
14.06
14.1
8.3
79.18
78.96
u/l
0.03
400
3081
109
514
2.44
13.80
2.4
1.8
—
—
—
0
0
246
1610
2.05
13.66
6.4
3.4
31.06
36.39
ng/l
0.49
184
1077
102
470
2.47
13.57
7.8
7.9
1.85
0.81
mmol/l
1.78
80
389
91
399
2.57
13.43
7.9
8.7
118.69
121.47
g/l
0.61
86
390
101
477
2.40
12.67
7.9
7.7
12.31
12.28
kpa
0.01
94
460
101
477
2.40
12.67
7.9
7.7
5.27
5.08
kpa
0.89
95
457
46
143
3.44
12.52
2.3
2.0
247.97
268.90
ug/l
0.09
46
137
99
476
2.35
11.88
4.4
4.7
212.50
245.63
u/l
3.09
94
454
332
2495
2.01
11.71
14.7
9.9
4.41
4.10
e9/l
1.62
313
2188
205
1326
1.93
11.14
5.4
3.1
0.00
0.01
estimate
0.99
91
405
100
496
2.27
11.11
2.4
1.8
—
—
—
0
0
179
1108
1.97
11.06
3.8
2.2
3.08
2.95
mg/l
0.30
164
966
73
318
2.52
10.82
7.4
4.1
134.08
85.49
ng/l
1.67
60
285
218
1458
1.89
10.55
5.0
3.4
7.19
8.03
mmol/l
1.62
197
1238
263
1869
1.87
10.50
14.0
6.1
1.21
1.21
mmol/l
0.20
251
1728
83
394
2.33
10.17
2.7
2.5
0.20
0.22
g/l
0.57
78
375
257
1832
1.84
9.98
2.4
2.1
94.97
95.65
pmol/l
0.08
159
1006
309
2337
1.86
9.85
6.1
3.7
0.00
0.00
estimate
-0.00
105
488
310
2353
1.85
9.70
6.1
3.8
0.00
0.02
estimate
0.79
99
461
189
1234
1.86
9.66
2.0
1.6
18.53
20.00
nmol/l
0.70
167
1059
206
1385
1.84
9.56
5.4
3.2
41.92
99.49
e6/l
0.62
183
1063
262
1901
1.81
9.39
3.5
2.5
68.82
75.13
nmol/l
3.11
240
1734
56
231
2.61
9.26
6.4
9.1
16.34
15.84
%
0.64
51
220
304
2312
1.82
9.26
6.1
3.7
0.00
0.00
estimate
0.50
103
483
180
1179
1.83
8.97
3.9
3.2
3215.71
1134.18
ng/l
1.57
164
1003
80
395
2.22
8.89
7.1
3.1
—
—
—
0
0
348
2777
1.86
8.85
7.7
4.3
14451.29
446.95
e6/l
—
7
42
97
518
2.09
8.83
3.0
2.8
8.69
7.71
umol/l
0.15
81
457
35
116
3.17
8.61
1.7
1.2
—
—
—
0
0
52
217
2.56
8.40
2.3
1.4
—
—
—
0
0
244
1776
1.74
8.30
6.2
3.6
0.00
0.02
estimate
1.39
90
408
26
73
3.70
8.23
5.6
2.5
5.17
5.00
kpa
0.80
26
73
151
958
1.83
8.22
4.3
2.5
5.36
6.08
e6/l
0.26
144
873
283
2154
1.73
8.14
5.2
3.1
129.52
117.81
ug/l
0.46
267
2039
196
1350
1.75
8.04
5.2
4.2
16.71
9.96
mg/mmol
0.55
133
860
384
3205
1.89
7.93
6.6
4.2
15.25
10.90
mm/h
5.22
364
3001
38
141
2.84
7.70
1.7
1.3
—
—
—
0
0
32
109
3.07
7.53
2.2
1.6
—
—
—
0
0
54
242
2.38
7.49
8.4
2.4
0.65
0.62
%
0.20
54
242
101
579
1.94
7.46
2.0
1.9
1.54
1.45
%
0.76
77
523
182
1269
1.69
6.91
6.5
3.8
0.00
0.02
estimate
1.15
95
465
467
4247
2.82
6.90
39.7
17.1
4.00
3.97
mmol/l
1.74
462
4160
32
115
2.91
6.88
2.4
1.5
—
—
—
0
0
174
1203
1.69
6.80
4.6
3.1
0.29
0.34
e6/l
0.31
152
877
124
783
1.78
6.69
5.0
3.9
97.78
334.49
ng/l
1.79
87
580
23
69
3.45
6.63
6.9
2.9
17.23
9.07
pmol/l
0.88
23
69
162
1117
1.67
6.31
3.9
2.8
335.09
343.49
umol/l
0.43
149
1002
79
443
1.93
6.18
3.3
2.1
322.55
390.83
nmol/l
2.62
74
419
28
100
2.91
6.10
14.0
5.7
131.86
183.75
iu/ml
—
7
8
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
99
2.83
5.62
3.8
2.6
0.41
0.41
iu/ml
0.00
17
52
147
1018
1.63
5.52
2.0
1.7
0.96
1.20
mg/l
1.04
127
790
20
63
3.27
5.37
1.5
1.5
—
—
—
0
0
461
4244
2.29
5.24
37.6
14.6
22.30
22.90
mg/l
0.17
424
3458
20
65
3.16
5.12
2.6
1.6
—
—
—
0
0
48
241
2.10
5.09
2.2
1.7
—
—
—
0
0
34
148
2.39
5.06
2.7
2.1
—
—
—
0
0
354
3037
1.58
4.98
6.0
3.3
58.21
45.66
u/l
1.24
338
2895
8
7
11.59
4.80
19.9
5.3
4.97
5.93
mmol/l
—
8
7
42
205
2.15
4.80
1.5
2.0
2.04
8.15
iu/ml
1.76
11
50
40
192
2.18
4.76
2.1
2.0
1.80
1.43
g/l
1.37
33
170
10
14
7.27
4.67
1.4
1.8
13.82
14.74
umol/l
—
10
14
20
69
2.98
4.65
2.1
1.3
—
—
—
0
0
31
135
2.38
4.62
2.4
2.7
—
—
—
0
0
25
99
2.61
4.54
1.7
1.4
—
—
—
0
0
16
49
3.34
4.50
2.1
1.4
—
—
—
0
0
31
138
2.33
4.41
2.5
1.9
—
—
—
0
0
32
146
2.27
4.31
1.5
1.5
0.11
0.05
iu/ml
—
6
27
19
67
2.91
4.27
2.1
1.3
—
—
—
0
0
441
4048
1.83
4.26
28.9
14.2
83.78
84.25
ml/min/173m2
0.14
428
3761
19
68
2.87
4.16
5.2
5.8
443.26
357.30
umol/l
0.42
19
61
48
262
1.92
4.07
11.6
8.1
25.59
24.64
mmol/l
0.61
48
262
24
100
2.47
3.95
1.7
1.2
205.00
273.30
u/ml
0.67
17
53
18
65
2.84
3.89
2.2
1.3
—
—
—
0
0
18
65
2.84
3.89
2.2
1.3
—
—
—
0
0
20
77
2.66
3.85
1.5
1.7
—
—
—
0
0
18
66
2.79
3.79
2.2
1.3
—
—
—
0
0
377
3357
1.52
3.79
5.4
4.4
14.58
14.62
pmol/l
0.13
357
3081
41
218
1.96
3.76
3.5
2.1
2040.28
5843.98
u/l
0.80
17
86
21
84
2.57
3.76
1.5
1.5
—
—
—
0
0
15
50
3.06
3.72
1.7
1.4
—
—
—
0
0
19
73
2.67
3.68
1.2
1.3
—
—
—
0
0
20
79
2.60
3.67
1.7
1.4
—
—
—
0
0
99
682
1.56
3.66
4.7
2.9
6.04
2.01
e6/l
0.76
71
333
6
6
10.10
3.50
7.0
7.3
—
—
—
0
0
15
53
2.89
3.38
1.4
1.2
—
—
—
0
0
41
227
1.88
3.36
1.8
1.6
0.30
0.33
mg/l
0.08
22
105
16
59
2.77
3.35
1.8
1.2
0.51
0.55
nmol/l
0.14
16
54
23
102
2.32
3.34
1.3
1.6
—
—
—
0
0
29
142
2.11
3.33
1.4
1.3
2.88
2.99
u/ml
—
5
16
12
33
3.70
3.31
1.6
2.7
—
—
—
0
0
25
116
2.22
3.28
4.7
3.1
3.88
2.25
ratio
0.25
17
66
29
143
2.09
3.28
1.5
1.3
3.10
6.28
u/ml
—
5
26
13
43
3.08
3.27
1.0
1.1
—
—
—
0
0
6
7
8.66
3.27
1.7
1.1
—
—
—
0
0
13
39
3.40
3.24
2.6
1.5
91.78
91.69
%
0.03
13
39
468
4437
2.04
3.23
19.8
11.7
26.03
26.73
u/l
0.39
463
4331
30
151
2.05
3.22
1.4
1.2
—
1.58
—
0
5
136
1027
1.45
3.21
6.5
3.7
1.02
1.02
kg/l
0.08
116
681
425
3928
1.59
3.17
9.3
6.1
41.55
38.90
mmol/mol
4.98
408
3712
17
67
2.59
3.16
1.1
1.1
—
—
—
0
0
124
924
1.46
3.13
1.8
1.6
—
—
—
0
0
146
1123
1.43
3.11
1.4
1.3
1.73
1.92
u/ml
0.07
56
318
22
99
2.28
3.11
1.1
1.1
3.01
2.09
u/ml
0.20
15
54
13
41
3.23
3.08
1.0
1.1
—
—
—
0
0
6
8
7.57
3.06
1.3
1.0
97.83
106.75
%
—
6
8
425
3939
1.57
3.01
5.0
4.1
1.36
1.28
mmol/l
1.14
398
3673
17
69
2.52
2.99
2.3
1.3
—
—
—
0
0
64
418
1.61
2.96
3.0
4.7
3.89
34.92
ug/l
0.97
50
343
17
70
2.48
2.91
1.2
1.5
—
—
—
0
0
26
130
2.06
2.86
1.4
1.4
349.67
305.16
ug/g
—
9
72
22
103
2.19
2.85
2.0
2.5
369.13
71.84
ug/min
0.50
16
59
20
90
2.27
2.84
2.4
1.4
134.20
162.26
au/ml
—
5
29
177
1427
1.37
2.82
4.2
3.5
2.36
2.35
mmol/l
0.19
162
1306
30
159
1.94
2.82
3.4
1.9
3.76
3.83
g/l
0.05
30
149
30
159
1.94
2.82
3.4
1.9
4.15
4.30
g/l
0.31
30
149
30
159
1.94
2.82
3.5
1.9
7.51
7.37
g/l
0.16
30
149
25
124
2.07
2.81
1.3
1.2
—
—
—
0
0
26
131
2.04
2.81
3.3
2.3
3.40
3.68
g/l
0.38
26
125
424
3943
1.53
2.78
6.6
5.3
1.80
1.89
mu/l
1.01
403
3674
9
23
3.96
2.78
1.2
1.5
—
—
—
0
0
480
4619
2.38
2.76
50.8
23.0
39.14
40.57
%
6.82
475
4574
480
4619
2.38
2.76
50.4
22.6
4.36
4.52
e12/l
7.89
475
4544
11
34
3.29
2.74
1.1
1.1
—
—
—
0
0
9
24
3.80
2.68
1.1
1.0
—
—
—
0
0
9
24
3.80
2.68
2.0
2.2
—
—
—
0
0
11
35
3.19
2.66
1.1
1.1
—
—
—
0
0
16
67
2.43
2.66
1.6
1.3
—
—
—
0
0
7
15
4.72
2.60
1.1
1.1
—
—
—
0
0
7
15
4.72
2.60
2.9
4.9
—
—
—
0
0
114
864
1.42
2.60
1.4
1.3
31.24
29.64
iu/ml
0.06
36
271
9
25
3.65
2.58
1.2
1.6
—
—
—
0
0
11
36
3.10
2.58
1.0
1.1
—
—
—
0
0
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
9
26
3.51
2.49
2.0
1.3
—
—
—
0
0
9
26
3.51
2.49
2.0
1.3
—
—
—
0
0
7
16
4.42
2.48
1.1
1.1
—
—
—
0
0
8
21
3.85
2.47
1.0
1.2
—
—
—
0
0
12
45
2.71
2.46
3.4
3.7
4.70
3.43
nmol/l
0.24
12
45
12
45
2.71
2.46
3.1
1.7
—
—
—
0
0
18
83
2.21
2.44
1.2
1.0
0.34
1.49
u/ml
1.16
13
40
133
1048
1.37
2.39
4.0
2.3
—
—
—
0
0
439
4141
1.54
2.39
5.7
4.8
1.39
1.45
mmol/l
2.20
419
3881
87
638
1.44
2.37
2.9
2.2
—
—
—
0
0
51
335
1.58
2.33
4.0
2.5
53.57
67.53
ml/min/173m2
1.75
30
145
105
799
1.40
2.33
1.4
1.3
47.10
9.78
u/ml
0.49
44
297
11
40
2.79
2.28
3.2
1.8
—
—
—
0
0
8
23
3.52
2.28
2.0
1.2
—
—
—
0
0
8
23
3.52
2.28
2.0
1.2
—
—
—
0
0
8
23
3.52
2.28
1.1
1.0
1511.88
1364.09
miu/ml
—
8
23
5
9
5.60
2.22
1.0
1.3
—
—
—
0
0
445
4222
1.54
2.21
6.3
5.5
2.50
2.74
mmol/l
7.41
425
3968
19
95
2.04
2.13
1.9
1.4
—
—
—
0
0
318
2867
1.31
2.13
4.2
3.3
—
—
—
0
0
439
4160
1.50
2.12
5.8
4.9
4.40
4.65
mmol/l
6.05
418
3915
32
510
0.60
2.08
1.9
1.9
3.61
3.50
ratio
0.14
27
399
25
140
1.83
2.05
3.9
1.9
10.47
10.52
g/l
0.01
25
129
16
76
2.14
2.04
1.4
1.2
—
—
—
0
0
16
76
2.14
2.04
1.4
1.2
—
—
—
0
0
6
15
4.04
2.04
2.2
2.6
30.06
44.51
umol/l
—
6
15
58
409
1.47
1.95
3.4
2.6
35.27
37.49
u/l
0.20
49
335
5
11
4.58
1.94
1.6
1.2
—
—
—
0
0
6
16
3.78
1.94
2.3
2.1
—
—
—
0
0
96
743
1.36
1.92
3.9
2.9
0.81
0.89
e6/l
0.18
69
393
19
101
1.92
1.83
1.5
1.3
486.50
153.63
e6/l
0.64
12
75
7
23
3.07
1.80
1.6
3.7
382.43
686.83
u/ml
—
7
23
26
155
1.72
1.76
1.3
1.2
9.17
10.26
u/l
0.19
21
126
7
24
2.94
1.73
1.0
1.1
18.57
22.33
u/l
—
7
24
7
24
2.94
1.73
1.0
1.1
55.57
93.50
u/l
—
7
24
5
13
3.87
1.72
2.8
3.3
5.49
4.63
kpa
—
5
13
5
13
3.87
1.72
2.8
3.3
12.08
10.62
kpa
—
5
13
45
311
1.49
1.69
2.4
2.4
5.42
6.52
ug/l
0.21
38
282
27
165
1.67
1.68
1.5
1.8
—
—
—
0
0
6
19
3.18
1.66
1.2
1.6
—
—
—
0
0
6
19
3.18
1.66
1.2
1.5
—
—
—
0
0
5
14
3.60
1.62
1.0
2.4
—
—
—
0
0
424
4033
1.36
1.61
6.1
4.8
6.26
5.88
mmol/l
4.41
410
3722
8
32
2.52
1.60
1.3
1.1
109.63
98.06
pmol/l
—
8
32
18
99
1.85
1.59
1.6
1.2
92.50
16.71
e6/l
—
10
70
11
50
2.23
1.58
1.5
2.3
29.18
33.08
pg
1.35
11
50
10
44
2.30
1.56
1.0
1.2
77.10
42.63
u/l
—
10
39
31
201
1.58
1.55
3.0
2.2
42.06
40.41
u/l
0.17
26
185
87
691
1.31
1.47
3.2
2.4
—
—
—
0
0
25
385
0.63
1.45
1.7
1.7
3.52
3.45
mmol/l
0.08
19
276
6
23
2.63
1.37
2.2
3.1
1.17
1.48
%
—
6
23
9
175
0.51
1.31
1.0
1.1
1.63
1.56
g/l
—
9
175
5
18
2.80
1.29
1.0
1.0
—
—
—
0
0
5
18
2.80
1.29
1.0
1.3
—
—
—
0
0
25
163
1.56
1.25
1.3
1.5
—
—
—
0
0
34
240
1.45
1.19
1.0
1.0
—
—
—
0
0
11
57
1.95
1.18
1.8
1.2
—
—
—
0
0
25
166
1.53
1.17
1.7
1.6
34.23
8.02
u/ml
—
7
36
5
20
2.51
1.15
1.2
3.0
160.60
193.50
u/l
—
5
20
23
151
1.55
1.13
2.8
2.0
2.94
3.02
g/l
0.17
23
141
20
127
1.60
1.13
1.8
2.0
2.11
4.34
iu/l
—
10
55
10
182
0.54
1.12
1.3
1.1
0.81
0.90
g/l
—
10
182
52
404
1.32
1.06
2.6
2.2
—
—
—
0
0
57
450
1.30
1.04
12.0
6.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
22
2.29
1.03
1.0
1.3
—
—
—
0
0
7
36
1.96
0.97
2.4
1.3
—
—
—
0
0
6
28
2.16
0.92
1.8
1.2
—
—
—
0
0
9
155
0.57
0.89
1.4
1.4
—
—
—
0
0
49
391
1.28
0.85
1.9
2.4
10.65
13.41
nmol/l
1.46
43
357
94
811
1.20
0.81
3.2
2.8
2.46
2.44
mmol/l
0.84
88
724
9
147
0.61
0.80
1.8
1.6
44.73
60.15
ug/l
—
9
130
33
252
1.33
0.79
10.3
9.8
24.96
24.31
mmol/l
0.34
33
246
18
123
1.48
0.78
1.6
1.3
—
—
—
0
0
32
244
1.33
0.77
1.3
1.3
15.84
23.98
iu/l
1.05
27
205
5
24
2.09
0.74
1.0
1.2
181.22
195.53
iu/ml
—
5
24
8
134
0.59
0.74
1.9
1.5
—
—
—
0
0
7
38
1.85
0.74
4.1
1.7
—
—
—
0
0
7
38
1.85
0.74
1.6
1.6
—
—
—
0
0
7
38
1.85
0.74
4.1
1.7
—
—
—
0
0
7
38
1.85
0.74
4.1
1.7
—
—
—
0
0
25
185
1.37
0.73
1.4
1.4
50.70
254.25
miu/ml
—
8
91
7
40
1.76
0.71
1.3
1.5
—
—
—
0
0
9
57
1.59
0.71
1.3
1.2
—
—
—
0
0
18
127
1.43
0.69
1.3
1.1
—
—
—
0
0
18
127
1.43
0.69
1.3
1.1
—
—
—
0
0
7
42
1.68
0.68
4.7
1.6
—
—
—
0
0
5
27
1.86
0.68
3.0
3.0
0.40
0.85
index
—
5
27
5
27
1.86
0.68
1.0
1.0
—
1.14
—
0
14
43
349
1.25
0.68
2.6
2.1
—
—
—
0
0
12
78
1.55
0.66
1.4
1.2
4.20
3.93
u/ml
—
5
29
7
44
1.60
0.65
1.4
1.2
—
—
—
0
0
5
29
1.73
0.64
1.2
1.3
213.16
156.60
pmol/l
—
5
29
147
1341
1.14
0.63
5.4
5.3
2.21
2.42
ug/l
0.19
129
1216
8
50
1.61
0.61
1.3
1.1
—
—
—
0
0
40
330
1.23
0.57
1.4
1.3
93.50
157.59
u/ml
1.17
17
134
11
73
1.52
0.56
1.2
1.1
—
—
—
0
0
22
170
1.31
0.52
1.8
1.3
—
—
—
0
0
6
40
1.51
0.51
1.2
1.0
—
—
—
0
0
6
41
1.47
0.50
2.7
1.7
—
—
—
0
0
7
46
1.53
0.48
1.4
1.2
—
—
—
0
0
7
46
1.53
0.48
1.4
1.2
—
—
—
0
0
7
50
1.41
0.45
1.4
1.2
—
—
—
0
0
9
127
0.70
0.44
1.2
1.6
—
—
—
0
0
5
35
1.43
0.39
1.6
3.4
387.20
995.86
mg
—
5
35
0
19
0.00
0.39
0.0
1.2
—
8.53
—
0
19
5
36
1.39
0.38
1.6
1.1
—
—
—
0
0
13
169
0.76
0.37
2.1
1.4
—
—
—
0
0
9
69
1.31
0.37
1.2
1.1
123.44
118.97
%
—
9
62
15
190
0.78
0.36
1.9
2.0
8.71
3.84
mg/l
—
10
147
15
117
1.29
0.35
3.6
2.0
0.00
0.00
g/l
-0.00
15
111
74
810
0.90
0.34
3.3
3.1
0.78
0.76
ug/l
0.08
43
498
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
7
54
1.30
0.30
1.3
1.2
—
—
—
0
0
8
63
1.27
0.28
1.6
1.2
1.72
3.15
ug/l
—
8
55
174
1811
0.94
0.25
2.0
1.9
1.54
1.37
mmol/l
1.51
148
1541
55
504
1.10
0.25
4.8
4.5
33.07
32.04
%
0.29
41
337
13
106
1.23
0.23
2.2
1.2
—
—
—
0
0
5
40
1.25
0.22
6.6
3.5
15.80
60.79
u/ml
—
5
40
5
42
1.19
0.21
2.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
28
249
1.13
0.21
1.2
1.3
—
—
—
0
0
12
99
1.22
0.19
1.4
1.3
—
—
—
0
0
6
51
1.18
0.19
2.0
1.9
13.33
13.31
%
—
6
51
102
1063
0.95
0.16
4.0
4.6
22.74
21.93
%
0.16
40
514
8
100
0.80
0.13
1.6
1.5
108.78
55.21
ug/l
—
8
100
5
48
1.04
0.09
2.6
3.2
—
—
—
0
0
6
54
1.11
0.09
1.3
1.1
101.17
98.79
%
—
6
48
16
146
1.10
0.08
1.5
1.5
—
—
—
0
0
7
66
1.06
0.08
1.9
1.6
—
—
—
0
0
23
215
1.07
0.07
4.3
2.7
136.28
42.09
u/ml
0.45
23
207
15
139
1.08
0.05
3.3
2.2
179.73
182.92
%
0.06
15
133
73
713
1.03
0.05
1.6
1.5
—
—
—
0
0
10
109
0.92
0.04
2.0
1.7
—
—
—
0
0
33
341
0.97
0.03
1.4
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
6
60
1.00
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_OTHER_FACTOR_ENVIRONMENT – Other factor of the environment
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).